NCTId,BriefTitle,OverallStatus,StudyType,Phases,Conditions,LeadSponsorName,StartDate,StudyFirstPostDate,LastUpdatePostDate,Timestamp
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-25T17:03:30.194190
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-25T17:03:30.194190
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-25T17:03:30.194190
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-25T17:03:30.194190
NCT03589573,Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Muscle Strength, Lower Extremity, Hamstring Contractures",Hacettepe University,2017-03-24,2018-07-18,2018-07-31,2024-10-25T17:03:30.194190
NCT01633866,Pediatric Radio Frequency Coils Generic,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Musculoskeletal Abnormalities","Children's Hospital Medical Center, Cincinnati",2012-07,2012-07-04,2023-09-28,2024-10-25T17:03:30.194190
NCT06491927,Long Term Follow-up for RGX-202,ENROLLING_BY_INVITATION,OBSERVATIONAL,,Duchenne Muscular Dystrophy,REGENXBIO Inc.,2024-05-08,2024-07-09,2024-07-09,2024-10-25T17:03:30.194190
NCT01931644,"At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions",COMPLETED,OBSERVATIONAL,,"All Diagnosed Health Conditions, ADD/ADHD, Alopecia Areata, Ankylosing Spondylitis, Asthma, Atopic Dermatitis Eczema, Beta Thalassemia, Bipolar Disorder, Breast Cancer, Celiac Disease, Cervical Cancer, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Colon Cancer, Colorectal Cancer, Crohn's Disease, Cystic Fibrosis, Depression, Diabetes Mellitus, Duchenne Muscular Dystrophy, Endometriosis, Epilepsy, Facioscapulohumeral Muscular Dystrophy, G6PD Deficiency, General Anxiety Disorder, Hepatitis B, Hereditary Hemorrhagic Telangiectasia, HIV/AIDS, Human Papilloma Virus, Huntington's Disease, Idiopathic Thrombocytopenic Purpura, Insomnia, Kidney Cancer, Leukemia, Lung Cancer, Lupus Nephritis, Lymphoma, Melanoma, Multiple Myeloma, Multiple Sclerosis, Myositis, Myotonic Dystrophy, Ovarian Cancer, Pancreatic Cancer, Parkinson's Disease, Polycystic Kidney Diseases, Prostate Cancer, Psoriasis, Psoriatic Arthritis, Rosacea, Scleroderma, Sickle Cell Anemia, Sickle Cell Trait, Sjogren's Syndrome, Skin Cancer, Spinal Muscular Atrophy, Systemic Lupus Erythematosus, Thrombotic Thrombocytopenic Purpura, Trisomy 21, Ulcerative Colitis",Sanguine Biosciences,2013-07,2013-08-29,2024-04-18,2024-10-25T17:03:30.194190
NCT03611244,Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device,RECRUITING,INTERVENTIONAL,NA,"Scoliosis Neuromuscular, Duchenne Muscular Dystrophy, Lordosis Lumbar",Seoul National University Hospital,2018-08-07,2018-08-02,2018-09-18,2024-10-25T17:03:30.194190
NCT02780492,Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"University College, London",2012-04-11,2016-05-23,2024-01-05,2024-10-25T17:03:30.194190
NCT00873782,Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophies, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy","University of North Carolina, Chapel Hill",2009-03,2009-04-02,2015-03-09,2024-10-25T17:03:30.194190
NCT03680365,Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Burden, Dependency, Disability Physical, Disease Management, Impairment, Rare Diseases","Jett Foundation, Inc.",2018-09-20,2018-09-21,2019-04-01,2024-10-25T17:03:30.194190
NCT02436720,Upper Limb Assessment in Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Catholic University of the Sacred Heart,2013-01,2015-05-07,2015-05-07,2024-10-25T17:03:30.194190
NCT06564974,Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy.,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Catalyst Pharmaceuticals, Inc.",2024-07-31,2024-08-21,2024-10-23,2024-10-25T17:03:30.194190
NCT03633565,Comparative Study of Strategies for Management of Duchenne Myopathy (DM),UNKNOWN,INTERVENTIONAL,PHASE4,Myopathy,Assiut University,2018-09,2018-08-16,2018-08-16,2024-10-25T17:03:30.194190
NCT00005574,Gentamicin Treatment of Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Becker Muscular Dystrophy, Duchenne Muscular Dystrophy",National Institute of Neurological Disorders and Stroke (NINDS),2000-02,2002-12-10,2008-03-04,2024-10-25T17:03:30.194190
NCT01826474,Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2013-01,2013-04-08,2017-12-08,2024-10-25T17:03:30.194190
NCT03675126,An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen),TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2018-12-19,2018-09-18,2024-09-19,2024-10-25T17:03:30.194190
NCT06363526,Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Muscular Dystrophy",University of Malaga,2024-05-05,2024-04-12,2024-04-12,2024-10-25T17:03:30.194190
NCT00207857,Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy,WITHDRAWN,OBSERVATIONAL,,"Duchenne's Muscular Dystrophy, Scoliosis",Children's Healthcare of Atlanta,2004-03,2005-09-21,2015-02-04,2024-10-25T17:03:30.194190
NCT04322357,Twice Weekly Steroids and Exercise as Therapy for DMD,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),University of Florida,2020-07-30,2020-03-26,2024-01-31,2024-10-25T17:03:30.194190
NCT06363357,"The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne, Orthotic Devices, Upper Extremity",Seoul National University Hospital,2024-04-20,2024-04-12,2024-06-21,2024-10-25T17:03:30.194190
NCT05715957,Follow-up Study on Female Carriers With DMD Gene Variants,NOT_YET_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","Rigshospitalet, Denmark",2023-03-01,2023-02-08,2023-02-09,2024-10-25T17:03:30.194190
NCT03552874,Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Limb Function, Respiratory Function Test",Hacettepe University,2017-01-01,2018-06-12,2018-06-12,2024-10-25T17:03:30.194190
NCT04349566,Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases,COMPLETED,OBSERVATIONAL,,"Becker Muscular Dystrophy, McArdle Disease, Limb-Girdle Muscular Dystrophy Type 2",Mads Peter Godtfeldt Stemmerik,2020-06-01,2020-04-16,2022-10-27,2024-10-25T17:03:30.194190
NCT01921374,Mother-caregivers of Children With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Other Diseases or Conditions,Monica Levy Andersen,2013-08,2013-08-13,2016-02-03,2024-10-25T17:03:30.194190
NCT04626674,A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-11-23,2020-11-12,2024-08-26,2024-10-25T17:03:30.194190
NCT00451074,Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Nationwide Children's Hospital,2007-03,2007-03-23,2012-03-23,2024-10-25T17:03:30.194190
NCT04287582,The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2019-04-03,2020-02-27,2020-02-27,2024-10-25T17:03:30.194190
NCT01847573,"Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy",TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Processa Pharmaceuticals,2013-05,2013-05-07,2020-09-03,2024-10-25T17:03:30.194190
NCT02369731,Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",PTC Therapeutics,2015-04-30,2015-02-24,2024-10-09,2024-10-25T17:03:30.194190
NCT02018731,L-citrulline and Metformin in Becker's Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker's Muscular Dystrophy (BMD),"University Hospital, Basel, Switzerland",2013-06,2013-12-23,2016-05-16,2024-10-25T17:03:30.194190
NCT06244082,Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping,RECRUITING,INTERVENTIONAL,PHASE2,"DMD, Duchenne Muscular Dystrophy, Duchenne, Exon 44","Avidity Biosciences, Inc.",2024-01-22,2024-02-06,2024-09-23,2024-10-25T17:03:30.194190
NCT03703882,Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",Catabasis Pharmaceuticals,2018-10-02,2018-10-12,2022-06-21,2024-10-25T17:03:30.194190
NCT00981266,Spectra Breast Implant Study,WITHDRAWN,INTERVENTIONAL,PHASE3,"Augmentation, Augmentation Revision, General Breast Enlargement, Post-lactational Involution, Asymmetry","Mentor Worldwide, LLC",2013-06,2009-09-22,2013-03-01,2024-10-25T17:03:30.194190
NCT02614820,"The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD",UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy (DMD),General Hospital of Chinese Armed Police Forces,2015-11,2015-11-25,2015-11-25,2024-10-25T17:03:30.194190
NCT05281120,Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Osteoporosis, Duchenne Muscular Dystrophy",Istituto Auxologico Italiano,2006-11,2022-03-16,2022-03-16,2024-10-25T17:03:30.194190
NCT02994030,Biomarker for Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Increased Lordosis/Scoliosis, Hyporeflexia, Duchenne Muscular Dystrophy, Red-Green Color Blindness, Lordosis, Scoliosis, Muscular Atrophy, Muscular Weakness",CENTOGENE GmbH Rostock,2018-08-20,2016-12-15,2022-03-24,2024-10-25T17:03:30.194190
NCT05575648,Dual Task in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2022-09-06,2022-10-12,2024-02-28,2024-10-25T17:03:30.194190
NCT03992430,A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-07-13,2019-06-20,2024-04-15,2024-10-25T17:03:30.194190
NCT05639257,Treatment of Myotonia - Lamotrigine Versus Namuscla,RECRUITING,INTERVENTIONAL,NA,Non-Dystrophic Myotonia,"Grete Andersen, MD",2022-12-05,2022-12-06,2022-12-06,2024-10-25T17:03:30.194190
NCT02819557,Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2016-06-09,2016-06-30,2020-08-28,2024-10-25T17:03:30.194190
NCT04129294,Exploratory Study of NS-089/NCNP-02 in DMD,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"National Center of Neurology and Psychiatry, Japan",2019-12-02,2019-10-16,2022-09-29,2024-10-25T17:03:30.194190
NCT02710591,Rimeporide in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",EspeRare Foundation,2016-03,2016-03-17,2019-07-18,2024-10-25T17:03:30.194190
NCT02295748,"An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort",COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,PTC Therapeutics,2014-12,2014-11-20,2017-12-08,2024-10-25T17:03:30.194190
NCT03319030,Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Ann & Robert H Lurie Children's Hospital of Chicago,2017-09-01,2017-10-24,2019-02-04,2024-10-25T17:03:30.194190
NCT04687020,Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-06-10,2020-12-29,2022-10-19,2024-10-25T17:03:30.194190
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-10-25T17:03:30.194190
NCT02310763,"A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Pfizer,2014-11-24,2014-12-08,2020-12-07,2024-10-25T17:03:30.194190
NCT05933057,"Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Italfarmaco,2024-02-19,2023-07-06,2024-09-19,2024-10-25T17:03:30.194190
NCT06594094,"An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)",NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophin (DMD),"HuidaGene Therapeutics Co., Ltd.",2024-10-30,2024-09-19,2024-10-01,2024-10-25T17:03:30.194190
NCT04906460,Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2021-09-28,2021-05-28,2024-02-28,2024-10-25T17:03:30.194190
NCT02434627,Sodium Nitrate for Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2015-06,2015-05-05,2020-01-13,2024-10-25T17:03:30.194190
NCT02484560,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,UNKNOWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,University of Gaziantep,2015-06,2015-06-29,2015-07-01,2024-10-25T17:03:30.194190
NCT04139460,CRT-P or CRT-D in Dilated Cardiomyopathy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Cardiomyopathy, Dilated, 3B",University Hospital Olomouc,2020-06,2019-10-25,2020-03-25,2024-10-25T17:03:30.194190
NCT02078076,IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère,COMPLETED,INTERVENTIONAL,NA,Duchenne or Severe Becker Myopathy,"Institut National de la Santé Et de la Recherche Médicale, France",2013-06,2014-03-05,2016-02-24,2024-10-25T17:03:30.194190
NCT05305976,Telerehabilitation in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Karadeniz Technical University,2021-01-11,2022-03-31,2022-03-31,2024-10-25T17:03:30.194190
NCT02418338,2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,"University Hospital, Montpellier",2014-01,2015-04-16,2019-06-07,2024-10-25T17:03:30.194190
NCT01772043,Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2012-09,2013-01-21,2015-07-28,2024-10-25T17:03:30.194190
NCT02037243,Disgust and Shame Based Safe Water and Handwashing Promotion,COMPLETED,INTERVENTIONAL,PHASE1,"Develop a New Group Version of the Becker-DeGroot-Marsckek (BDM) Auction to Measure Willingness to Pay of Compound Members for Shared Hardware., Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure., Identify New Methods for Measuring Hand Washing and Water Treatment Behaviour., Compare the Effectiveness of the Disgust and Shame Based Interventions With Standard Public Health Interventions.","International Centre for Diarrhoeal Disease Research, Bangladesh",2011-08,2014-01-15,2015-06-12,2024-10-25T17:03:30.194190
NCT06109103,Telerehabilitation-based Motor Imagery Training in Children With Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2023-12-15,2023-10-31,2023-10-31,2024-10-25T17:03:30.194190
NCT06378203,Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI],RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophies, Limb Girdle Muscular Dystrophy, Facio-Scapulo-Humeral Dystrophy, Becker Muscular Dystrophy",IRCCS Eugenio Medea,2023-12-15,2024-04-22,2024-04-22,2024-10-25T17:03:30.194190
NCT05291091,Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON),RECRUITING,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2022-07-06,2022-03-22,2024-09-19,2024-10-25T17:03:30.194190
NCT03689660,"Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback",UNKNOWN,INTERVENTIONAL,NA,"Neuromuscular Disease, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Virtual Reality, Biofeedback",Merve Kurt,2019-02-01,2018-09-28,2022-06-22,2024-10-25T17:03:30.194190
NCT00759876,Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2008-08-13,2008-09-25,2020-10-29,2024-10-25T17:03:30.194190
NCT03067831,Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Stem Cells Arabia,2015-09,2017-03-01,2020-03-17,2024-10-25T17:03:30.194190
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-10-25T17:03:30.194190
NCT03648827,A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2018-12-21,2018-08-27,2022-04-05,2024-10-25T17:03:30.194190
NCT05257473,Defining Endpoints in Becker Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Becker Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy in Children, Muscular Dystrophy, Becker",Virginia Commonwealth University,2022-04-13,2022-02-25,2024-10-04,2024-10-25T17:03:30.194190
NCT03179631,Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2017-07-06,2017-06-07,2024-01-18,2024-10-25T17:03:30.194190
NCT05540860,A Study of EDG-5506 in Children with Duchenne Muscular Dystrophy (LYNX),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2022-10-24,2022-09-15,2024-09-19,2024-10-25T17:03:30.194190
NCT06224660,Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,PHASE1,DMD-Associated Dilated Cardiomyopathy,Sardocor Corp.,2024-03,2024-01-25,2024-01-25,2024-10-25T17:03:30.194190
NCT04428476,Open-label Extension of the HOPE-2 Trial,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Capricor Inc.,2020-07-20,2020-06-11,2024-07-24,2024-10-25T17:03:30.194190
NCT01009294,Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD),TERMINATED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",PTC Therapeutics,2010-01-13,2009-11-06,2020-07-29,2024-10-25T17:03:30.194190
NCT05429372,Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Pfizer,2022-08-08,2022-06-23,2024-04-04,2024-10-25T17:03:30.194190
NCT04254172,A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy,TERMINATED,OBSERVATIONAL,,Duchenne Muscular Dystrophy (DMD),Pfizer,2020-02-19,2020-02-05,2021-10-15,2024-10-25T17:03:30.194190
NCT01753804,A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.,TERMINATED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2012-09-01,2012-12-20,2017-12-08,2024-10-25T17:03:30.194190
NCT03907072,Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2019-09-04,2019-04-08,2021-05-20,2024-10-25T17:03:30.194190
NCT05464446,Examination of Lower Urinary System Symptoms With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Lower Urinary Tract Symptoms, Muscle Weakness, Posture Disorders in Children, Lumbar Lordosis, Pelvic Floor Muscle Weakness, Quality of Life",Lokman Hekim Üniversitesi,2021-10-01,2022-07-19,2022-07-19,2024-10-25T17:03:30.194190
NCT02740972,Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2016-12,2016-04-15,2021-12-07,2024-10-25T17:03:30.194190
NCT03879304,Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne and Becker Types",University of Malaga,2021-03-15,2019-03-18,2024-05-13,2024-10-25T17:03:30.194190
NCT04972604,CureDuchenne Link®: A Resource for Research,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",CureDuchenne,2021-07-09,2021-07-22,2024-08-20,2024-10-25T17:03:30.194190
NCT00033189,An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2001-09,2002-04-09,2010-11-16,2024-10-25T17:03:30.194190
NCT03406780,A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic, Muscular Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",Capricor Inc.,2018-03-04,2018-01-23,2020-06-05,2024-10-25T17:03:30.194190
NCT03373968,Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study,ENROLLING_BY_INVITATION,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,Italfarmaco,2017-10-24,2017-12-14,2023-11-07,2024-10-25T17:03:30.194190
NCT01539772,Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping,UNKNOWN,OBSERVATIONAL,,Becker Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2012-04,2012-02-28,2018-06-15,2024-10-25T17:03:30.194190
NCT05688072,Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne Type",Cairo University,2023-01-15,2023-01-18,2023-04-18,2024-10-25T17:03:30.194190
NCT01183767,Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,"Charite University, Berlin, Germany",2010-12-30,2010-08-18,2021-07-29,2024-10-25T17:03:30.194190
NCT01834040,Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne Muscular Dystrophy","Chaitanya Hospital, Pune",2014-09,2013-04-17,2014-09-17,2024-10-25T17:03:30.194190
NCT04632940,Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,FibroGen,2021-03-03,2020-11-17,2024-08-26,2024-10-25T17:03:30.194190
NCT01610440,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Shenzhen Beike Bio-Technology Co., Ltd.",2011-10,2012-06-04,2012-11-30,2024-10-25T17:03:30.194190
NCT00243789,Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2005-09,2005-10-25,2011-10-27,2024-10-25T17:03:30.194190
NCT04956289,"Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-07-01,2021-07-09,2024-08-20,2024-10-25T17:03:30.194190
NCT02109692,Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies,UNKNOWN,INTERVENTIONAL,NA,"Muscular Dystrophies, Becker Muscular Dystrophy, Duchenne Muscular Dystrophy","University Hospital, Montpellier",2014-05-19,2014-04-10,2018-05-15,2024-10-25T17:03:30.194190
NCT03236662,(-)- Epicatechin Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Craig McDonald, MD",2016-11,2017-08-02,2021-11-24,2024-10-25T17:03:30.194190
NCT04782440,The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Marmara University,2021-04,2021-03-04,2021-03-04,2024-10-25T17:03:30.194190
NCT01462292,A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Muscular Dystrophies,GlaxoSmithKline,2011-10-26,2011-10-31,2017-10-16,2024-10-25T17:03:30.194190
NCT04353167,Examination of the Relationship Between Foot - Body Posture and Balance and Gait in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Foot Posture, Balance, Gait Disorders, Neurologic, Body Posture",Hacettepe University,2020-03-15,2020-04-20,2022-07-27,2024-10-25T17:03:30.194190
NCT06606340,"A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice",ENROLLING_BY_INVITATION,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2019-01-07,2024-09-23,2024-09-23,2024-10-25T17:03:30.194190
NCT02636686,Extension Study of Drisapersen in DMD Subjects,NO_LONGER_AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,,2015-12-22,2018-01-24,2024-10-25T17:03:30.194190
NCT02315339,European Home Mechanical Ventilation Registry,TERMINATED,OBSERVATIONAL,,"Pulmonary Disease, Chronic Obstructive, Amyotrophic Lateral Sclerosis, Spinal Cord Injury, Muscular Dystrophies, Obesity Hypoventilation Syndrome, Kyphoscoliosis, Congenital Central Hypoventilation Syndrome, Duchenne Muscular Dystrophy, Myopathies, Myotonic Dystrophy",ResMed,2014-08,2014-12-11,2020-04-09,2024-10-25T17:03:30.194190
NCT03039686,"Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,Hoffmann-La Roche,2017-07-06,2017-02-01,2020-12-21,2024-10-25T17:03:30.194190
NCT05564962,Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD),COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Gait Disorders in Children",Hacettepe University,2021-01-19,2022-10-04,2022-10-04,2024-10-25T17:03:30.194190
NCT03936894,Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Children's National Research Institute,2019-05-01,2019-05-03,2023-09-21,2024-10-25T17:03:30.194190
NCT05753462,"Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Sqy Therapeutics,2023-04-26,2023-03-03,2024-04-01,2024-10-25T17:03:30.194190
NCT02858362,Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Summit Therapeutics,2016-06,2016-08-08,2020-01-02,2024-10-25T17:03:30.194190
NCT02470962,Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne / Becker Muscular Dystrophy,"University Children's Hospital, Zurich",2015-05,2015-06-12,2019-07-12,2024-10-25T17:03:30.194190
NCT05185622,A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2022-03-21,2022-01-11,2024-10-16,2024-10-25T17:03:30.194190
NCT03354039,Tamoxifen in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"University Hospital, Basel, Switzerland",2018-06-12,2017-11-27,2022-12-20,2024-10-25T17:03:30.194190
NCT05135663,Extension Study of NS-089/NCNP-02 in DMD,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),"Nippon Shinyaku Co., Ltd.",2021-06-23,2021-11-26,2023-03-03,2024-10-25T17:03:30.194190
NCT01396239,Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2011-07,2011-07-18,2020-03-30,2024-10-25T17:03:30.194190
NCT02036463,A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy,WITHDRAWN,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),Ann & Robert H Lurie Children's Hospital of Chicago,2014-11,2014-01-15,2015-02-18,2024-10-25T17:03:30.194190
NCT04821063,Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval,COMPLETED,INTERVENTIONAL,PHASE1,"Duchenne and Becker Muscular Dystrophy, Polycytemia Vera",Italfarmaco,2021-04-13,2021-03-29,2024-01-11,2024-10-25T17:03:30.194190
NCT06328725,Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,ENCell,2024-03,2024-03-25,2024-03-25,2024-10-25T17:03:30.194190
NCT02194725,"Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy",COMPLETED,OBSERVATIONAL,,Stress,National Human Genome Research Institute (NHGRI),2014-07-06,2014-07-18,2018-04-05,2024-10-25T17:03:30.194190
NCT06174025,Validity and Reliability of the 6 Minute Pegboard Ring Test,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Çağtay Maden,2023-06-30,2023-12-18,2024-01-12,2024-10-25T17:03:30.194190
NCT03507530,Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,"Neuromuscular Diseases, Duchenne Muscular Dystrophy, Dystrophy, Dystrophy, Muscular",Canan İpek,2018-04,2018-04-25,2018-04-27,2024-10-25T17:03:30.194190
NCT02147639,Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3",Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2013-10,2014-05-28,2020-01-14,2024-10-25T17:03:30.194190
NCT06013839,TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy,RECRUITING,INTERVENTIONAL,PHASE2,DMD-Associated Dilated Cardiomyopathy,Constant Therapeutics LLC,2023-08-31,2023-08-28,2024-01-23,2024-10-25T17:03:30.194190
NCT06450639,An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Hoffmann-La Roche,2024-10-31,2024-06-10,2024-10-23,2024-10-25T17:03:30.194190
NCT06138639,A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE),RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Solid Biosciences Inc.,2024-05-06,2023-11-18,2024-10-15,2024-10-25T17:03:30.194190
NCT01826422,Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne","Coordinación de Investigación en Salud, Mexico",2013-03,2013-04-08,2018-03-09,2024-10-25T17:03:30.194190
NCT01834066,Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne Muscular Dystrophy,","Chaitanya Hospital, Pune",2014-09,2013-04-17,2014-09-17,2024-10-25T17:03:30.194190
NCT04336826,A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to <2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),COMPLETED,INTERVENTIONAL,PHASE2,Nonsene Mutation Duchenne Muscular Dystrophy,PTC Therapeutics,2021-12-29,2020-04-07,2024-04-01,2024-10-25T17:03:30.194190
NCT04371666,Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,FibroGen,2020-08-10,2020-05-01,2024-03-12,2024-10-25T17:03:30.194190
NCT03979157,Non-invasive Molecular Imaging of Muscle Structure (MSOT_muscles),COMPLETED,INTERVENTIONAL,NA,Muscular Diseases,University of Erlangen-Nürnberg Medical School,2019-10-14,2019-06-07,2020-07-07,2024-10-25T17:03:30.194190
NCT02704325,Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2,WITHDRAWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Kevin Flanigan,2016-04,2016-03-10,2018-02-06,2024-10-25T17:03:30.194190
NCT02752048,A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2016-05,2016-04-26,2020-04-20,2024-10-25T17:03:30.194190
NCT05280730,Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Virginia Commonwealth University,2022-02-02,2022-03-15,2024-04-16,2024-10-25T17:03:30.194190
NCT00758225,"Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2008-09,2008-09-25,2011-06-01,2024-10-25T17:03:30.194190
NCT00428935,Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Nationwide Children's Hospital,2006-03,2007-01-30,2013-02-05,2024-10-25T17:03:30.194190
NCT02165358,Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I,COMPLETED,OBSERVATIONAL,,"Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2I","Rigshospitalet, Denmark",2014-06,2014-06-17,2016-11-11,2024-10-25T17:03:30.194190
NCT01239758,Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",2010-10,2010-11-11,2013-02-01,2024-10-25T17:03:30.194190
NCT03238235,Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,Italfarmaco,2017-12-12,2017-08-03,2022-01-26,2024-10-25T17:03:30.194190
NCT03558958,Safety and Efficacy of P-188 NF in DMD Patients,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Phrixus Pharmaceuticals, Inc.",2018-08-08,2018-06-15,2023-01-11,2024-10-25T17:03:30.194190
NCT05019625,Biomarker Development for Muscular Dystrophies,RECRUITING,OBSERVATIONAL,,"Myotonic Dystrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy",Massachusetts General Hospital,2015-02-20,2021-08-25,2023-10-06,2024-10-25T17:03:30.194190
NCT01478022,"To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20",COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),"Parent Project, Italy",2011-10,2011-11-23,2018-08-31,2024-10-25T17:03:30.194190
NCT00799266,An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids,COMPLETED,INTERVENTIONAL,PHASE3,Osteoporosis,Novartis Pharmaceuticals,2008-12-04,2008-11-27,2020-09-02,2024-10-25T17:03:30.194190
NCT02081625,Exploratory Study of NS-065/NCNP-01 in DMD,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"National Center of Neurology and Psychiatry, Japan",2013-06,2014-03-07,2020-02-26,2024-10-25T17:03:30.194190
NCT05670730,Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2","Duchenne Muscular Dystrophy, Exon 44","Avidity Biosciences, Inc.",2022-11-09,2023-01-04,2024-09-23,2024-10-25T17:03:30.194190
NCT05126758,A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,PHASE3,"Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic, Muscular Diseases, Neuromuscular Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn, Nervous System Diseases",Capricor Inc.,2022-06-22,2021-11-19,2024-07-23,2024-10-25T17:03:30.194190
NCT06124196,Wearable Technology to Evaluate Hyperglycemia and HRV in DMD,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Vanderbilt University Medical Center,2024-03-20,2023-11-09,2024-04-01,2024-10-25T17:03:30.194190
NCT06540365,Applying the Pathways and Resources for Engagement and Participation Protocol Among People With Muscles Dystrophies,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",University of Haifa,2024-08,2024-08-06,2024-08-06,2024-10-25T17:03:30.194190
NCT04004065,"Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment",ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2019-06-26,2019-07-01,2024-10-03,2024-10-25T17:03:30.194190
NCT01978366,Open Label Extension Study of HT-100 in Patients With DMD,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Processa Pharmaceuticals,2013-10,2013-11-07,2020-09-03,2024-10-25T17:03:30.194190
NCT01506518,Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne","University of North Carolina, Chapel Hill",2012-01,2012-01-10,2021-08-02,2024-10-25T17:03:30.194190
NCT06290713,Vasodilator and Exercise Study for DMD (VASO-REx),RECRUITING,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in Children, Vasodilation, Exercise, DMD",University of Florida,2024-06-05,2024-03-04,2024-06-25,2024-10-25T17:03:30.194190
NCT04173234,Aerobic Exercise in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2019-04-11,2019-11-21,2021-09-30,2024-10-25T17:03:30.194190
NCT01385917,Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2011-10,2011-06-30,2016-04-12,2024-10-25T17:03:30.194190
NCT01648634,Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Duchenne Muscular Dystrophy, Cardiomyopathy, Heart Failure",Assistance Publique - Hôpitaux de Paris,2012-02-13,2012-07-24,2021-09-28,2024-10-25T17:03:30.194190
NCT00893334,Evaluation of Limb-Girdle Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency), Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency), Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)",Cooperative International Neuromuscular Research Group,2009-04,2009-05-06,2014-03-07,2024-10-25T17:03:30.194190
NCT04386304,Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Epirium Bio Inc.,2020-07-13,2020-05-13,2022-03-23,2024-10-25T17:03:30.194190
NCT03513367,The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"University Hospital, Toulouse",2018-09-19,2018-05-01,2019-04-18,2024-10-25T17:03:30.194190
NCT01540604,"CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers",COMPLETED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",RSPR Pharma AB,,2012-02-29,2012-10-02,2024-10-25T17:03:30.194190
NCT02329769,"Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2014-12,2015-01-01,2017-12-08,2024-10-25T17:03:30.194190
NCT00004646,"Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,National Center for Research Resources (NCRR),1995-04,2000-02-25,2005-06-24,2024-10-25T17:03:30.194190
NCT06337669,Characterization of DupEx2 Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",IRCCS San Raffaele,2022-01-31,2024-03-29,2024-03-29,2024-10-25T17:03:30.194190
NCT00110669,High-dose Prednisone in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2004-01,2005-05-13,2011-10-27,2024-10-25T17:03:30.194190
NCT04768062,Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-04-13,2021-02-24,2024-02-14,2024-10-25T17:03:30.194190
NCT02500381,Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2016-09-28,2015-07-16,2024-10-01,2024-10-25T17:03:30.194190
NCT05436210,Postural and Anthropometric Properties of Foot and Ankle of Patients With DMD,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Ambulation Difficulty, Posture Disorders in Children, Ambulation Disorder, Neurologic",Hacettepe University,2022-06-23,2022-06-29,2023-01-04,2024-10-25T17:03:30.194190
NCT02235844,Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne's Muscular Dystrophy,"Allergy and Asthma Consultants, Wichita, Kansas",2014-09,2014-09-10,2019-09-16,2024-10-25T17:03:30.194190
NCT01081080,Cardiac Magnetic Resonance in Children With Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy",Cooperative International Neuromuscular Research Group,2010-04,2010-03-05,2013-01-11,2024-10-25T17:03:30.194190
NCT02972580,Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",Nationwide Children's Hospital,2016-06,2016-11-23,2024-08-27,2024-10-25T17:03:30.194190
NCT06066580,Open-Label Extension of EDG-5506 in Participants with Becker Muscular Dystrophy,ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2023-11-02,2023-10-04,2024-10-24,2024-10-25T17:03:30.194190
NCT03760029,A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Pfizer,2019-07-24,2018-11-30,2024-09-19,2024-10-25T17:03:30.194190
NCT00390104,Molecular Analysis of Patients With Neuromuscular Disease,RECRUITING,OBSERVATIONAL,,"Neuromuscular; Disorder, Hereditary, Duchenne/Becker Muscular Dystrophy, Limb-girdle Muscular Dystrophy",Boston Children's Hospital,2002-01,2006-10-19,2023-04-24,2024-10-25T17:03:30.194190
NCT01954940,Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Children's Hospital of Eastern Ontario,2013-03,2013-10-07,2018-08-31,2024-10-25T17:03:30.194190
NCT06053814,NS-050/NCNP-03 in Boys With DMD (Meteor50),NOT_YET_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2024-07,2023-09-26,2024-02-15,2024-10-25T17:03:30.194190
NCT06186310,Effectiveness of Aquatic Therapy in Children With Duchenne and Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne or Becker Muscular Dystrophy,Gaziosmanpasa Research and Education Hospital,2023-11-05,2024-01-02,2024-03-12,2024-10-25T17:03:30.194190
NCT06539169,FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases,RECRUITING,OBSERVATIONAL,,"Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis, Amyotrophic Lateral Sclerosis, Creutzfeld-Jakob Disease, Cystic Fibrosis, Duchenne Muscular Dystrophy, Early-Onset Alzheimer Disease, Ehlers-Danlos Syndrome, Huntington Disease, Gaucher Disease, GM1 Gangliosidosis, Myasthenia Gravis, Pompe Disease, Sickle Cell Disease, Transthyretin Amyloid Cardiomyopathy, Rare Diseases",xCures,2024-06-10,2024-08-06,2024-08-14,2024-10-25T17:03:30.194190
NCT02196467,Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,CHU de Quebec-Universite Laval,2014-05,2014-07-22,2021-01-29,2024-10-25T17:03:30.194190
NCT01098708,This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Washington University School of Medicine,2010-03,2010-04-05,2017-01-18,2024-10-25T17:03:30.194190
NCT04587908,A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2020-11-01,2020-10-14,2024-08-14,2024-10-25T17:03:30.194190
NCT06241950,A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74),ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2024-01-29,2024-02-05,2024-08-13,2024-10-25T17:03:30.194190
NCT00159250,Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Imperial College London,2007-10-26,2005-09-12,2019-12-05,2024-10-25T17:03:30.194190
NCT04120168,Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Pompe Disease (Late-onset)","Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition",2019-04-01,2019-10-09,2022-10-24,2024-10-25T17:03:30.194190
NCT01580501,PDE Inhibitors in DMD Study (Acute Dosing Study),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Cedars-Sinai Medical Center,2012-03,2012-04-19,2014-01-28,2024-10-25T17:03:30.194190
NCT02907619,An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Pfizer,2016-10-13,2016-09-20,2020-11-23,2024-10-25T17:03:30.194190
NCT06574919,Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital,RECRUITING,OBSERVATIONAL,,Inherited Non-Duchenne Myopathies,Sohag University,2024-08-01,2024-08-28,2024-08-28,2024-10-25T17:03:30.194190
NCT02814019,A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy (DMD),Santhera Pharmaceuticals,2016-09,2016-06-27,2021-12-03,2024-10-25T17:03:30.194190
NCT04668716,Brain Involvement in Dystrophinopathies Part 2,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",Great Ormond Street Hospital for Children NHS Foundation Trust,2021-10-11,2020-12-16,2024-07-22,2024-10-25T17:03:30.194190
NCT02241434,Stem Cell Therapy in Duchenne Muscular Dystrophy,WITHDRAWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Neurogen Brain and Spine Institute,2009-01,2014-09-16,2018-10-25,2024-10-25T17:03:30.194190
NCT06392724,A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy (DMD),Peking Union Medical College Hospital,2024-07,2024-04-30,2024-07-08,2024-10-25T17:03:30.194190
NCT04433234,"Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy",ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Daiichi Sankyo Co., Ltd.",2020-06-30,2020-06-16,2024-08-29,2024-10-25T17:03:30.194190
NCT04607824,Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Sao Paulo,2014-03,2020-10-29,2020-10-29,2024-10-25T17:03:30.194190
NCT03127241,User-centred Assistive System for Arm Functions in Neuromuscular Subjects,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Becker, Muscular Dystrophy, Limb-Girdle Type 2",Politecnico di Milano,2017-06-16,2017-04-25,2019-12-10,2024-10-25T17:03:30.194190
NCT02167217,Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Washington University School of Medicine,2014-04-17,2014-06-19,2018-12-21,2024-10-25T17:03:30.194190
NCT03789734,Safety Study of BLS-M22 in Healthy Volunteers,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",BioLeaders Corporation,2019-06-04,2018-12-31,2021-04-22,2024-10-25T17:03:30.194190
NCT03777319,Spironolactone Versus Prednisolone in DMD,TERMINATED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",Kevin Flanigan,2018-12-05,2018-12-17,2023-10-23,2024-10-25T17:03:30.194190
NCT06295718,Tele-assessment of Functional Performance and Quality of Life in Patients With Duchenne Muscular Dystrophy: Validity and Reliability Study,ENROLLING_BY_INVITATION,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Sahra Şirvan,2023-07-01,2024-03-06,2024-03-06,2024-10-25T17:03:30.194190
NCT04583917,Brain Involvement in Dystrophinopathies Part 1,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",Great Ormond Street Hospital for Children NHS Foundation Trust,2021-03-30,2020-10-12,2024-07-22,2024-10-25T17:03:30.194190
NCT05982119,Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study,RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy 1, Charcot-Marie-Tooth, Centronuclear Myopathy, Congenital Muscular Dystrophy",Laurent Servais,2020-07-10,2023-08-08,2024-05-30,2024-10-25T17:03:30.194190
NCT01254019,A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Muscular Dystrophies,GlaxoSmithKline,2010-12-02,2010-12-06,2019-01-28,2024-10-25T17:03:30.194190
NCT02592941,"Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy",APPROVED_FOR_MARKETING,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,PTC Therapeutics,,2015-10-30,2018-02-28,2024-10-25T17:03:30.194190
NCT03863119,Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy,AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,,2019-03-05,2023-11-09,2024-10-25T17:03:30.194190
NCT06270719,An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2024-02-07,2024-02-21,2024-09-03,2024-10-25T17:03:30.194190
NCT03917719,An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Catabasis Pharmaceuticals,2019-03-14,2019-04-17,2020-11-23,2024-10-25T17:03:30.194190
NCT01910649,"A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration",TERMINATED,INTERVENTIONAL,PHASE2,Muscular Dystrophies,BioMarin Pharmaceutical,2008-03,2013-07-29,2016-11-06,2024-10-25T17:03:30.194190
NCT02376816,Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Jerry R. Mendell,2015-03,2015-03-03,2017-11-24,2024-10-25T17:03:30.194190
NCT01890616,Constipation and Gut Transit in DMD Patients,COMPLETED,OBSERVATIONAL,,"Constipation, DMD","Children's Hospital Medical Center, Cincinnati",2013-05-01,2013-07-02,2020-09-16,2024-10-25T17:03:30.194190
NCT03769116,"A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2018-12-05,2018-12-07,2023-10-25,2024-10-25T17:03:30.194190
NCT01182324,"The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,National Human Genome Research Institute (NHGRI),2010-07-30,2010-08-16,2018-04-05,2024-10-25T17:03:30.194190
NCT02161835,Relations Between Myotonia and Fitness,COMPLETED,INTERVENTIONAL,NA,Congenital Myotonia,"Grete Andersen, MD",2014-04,2014-06-12,2015-05-14,2024-10-25T17:03:30.194190
NCT05601986,Motor Imagery on Children With DMD on Gait and Balance Functions,RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Gülsena Utku,2022-12-16,2022-11-01,2024-02-29,2024-10-25T17:03:30.194190
NCT02606136,"Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,FibroGen,2016-01-04,2015-11-17,2024-08-27,2024-10-25T17:03:30.194190
NCT05558813,Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP),NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Assistance Publique - Hôpitaux de Paris,2024-11,2022-09-28,2023-10-30,2024-10-25T17:03:30.194190
NCT03786913,Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases,COMPLETED,OBSERVATIONAL,,"Inflammatory Myopathy, Duchenne Muscular Dystrophy",Benha University,2016-03-08,2018-12-26,2019-02-08,2024-10-25T17:03:30.194190
NCT00308113,CoQ10 and Prednisone in Non-Ambulatory DMD,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2007-04,2006-03-29,2013-11-08,2024-10-25T17:03:30.194190
NCT03534349,Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Performance, Flexibility",Hacettepe University,2017-01,2018-05-23,2018-05-24,2024-10-25T17:03:30.194190
NCT03541070,The Effect of Kinesiology Taping on Balance in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Balance, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-30,2018-05-30,2024-10-25T17:03:30.194190
NCT01957059,A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2013-06,2013-10-08,2017-12-08,2024-10-25T17:03:30.194190
NCT03340675,Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated",Cumberland Pharmaceuticals,2020-10-19,2017-11-13,2024-10-23,2024-10-25T17:03:30.194190
NCT04054375,Weekly Steroids in Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Limb-girdle Muscular Dystrophy, Becker Muscular Dystrophy",Northwestern University,2019-07-01,2019-08-13,2023-09-21,2024-10-25T17:03:30.194190
NCT02090959,An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy,TERMINATED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2014-03-20,2014-03-19,2020-08-11,2024-10-25T17:03:30.194190
NCT03947112,Physical Activity Level of Norwegian Boys With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Haukeland University Hospital,2020-08-20,2019-05-13,2021-12-29,2024-10-25T17:03:30.194190
NCT01803412,"A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects",TERMINATED,INTERVENTIONAL,PHASE3,Muscular Dystrophies,BioMarin Pharmaceutical,2013-05-01,2013-03-04,2018-06-14,2024-10-25T17:03:30.194190
NCT03218995,Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2017-08-16,2017-07-17,2021-12-09,2024-10-25T17:03:30.194190
NCT05330195,Bicycle Ergometer Training in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2022-04-18,2022-04-15,2023-10-11,2024-10-25T17:03:30.194190
NCT01982695,Cardiomyopathy in DMD: Lisinopril vs. Losartan,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy (DMD), Cardiomyopathy",Nationwide Children's Hospital,2009-03,2013-11-13,2017-03-21,2024-10-25T17:03:30.194190
NCT01451281,"Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy",COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Muscular Disease",National Institute of Neurological Disorders and Stroke (NINDS),2011-09-15,2011-10-13,2019-05-22,2024-10-25T17:03:30.194190
NCT03655223,Early Check: Expanded Screening in Newborns,ENROLLING_BY_INVITATION,OBSERVATIONAL,,"Spinal Muscular Atrophy, Fragile X Syndrome, Fragile X - Premutation, Duchenne Muscular Dystrophy, Hyperinsulinemic Hypoglycemia, Familial 1, Diabetes Mellitus, Adrenoleukodystrophy, Neonatal, Medium-chain Acyl-CoA Dehydrogenase Deficiency, Very Long Chain Acyl Coa Dehydrogenase Deficiency, Beta-ketothiolase Deficiency, Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency, Primary Hyperoxaluria Type 1, Congenital Bile Acid Synthesis Defect Type 2, Pyridoxine-Dependent Epilepsy, Hereditary Fructose Intolerance, Hypophosphatasia, Hyperargininemia, Mucopolysaccharidosis Type 6, Argininosuccinic Aciduria, Citrullinemia, Type I, Wilson Disease, Maple Syrup Urine Disease, Type 1A, Maple Syrup Urine Disease, Type 1B, Biotinidase Deficiency, Neonatal Severe Primary Hyperparathyroidism, Intrinsic Factor Deficiency, Usher Syndrome Type 1D/F Digenic (Diagnosis), Cystic Fibrosis, Stickler Syndrome Type 2, Stickler Syndrome Type 1, Alport Syndrome, Autosomal Recessive, Alport Syndrome, X-Linked, Carbamoyl Phosphate Synthetase I Deficiency Disease, Carnitine Palmitoyl Transferase 1A Deficiency, Carnitine Palmitoyltransferase II Deficiency, Cystinosis, Chronic Granulomatous Disease, Cerebrotendinous Xanthomatoses, Maple Syrup Urine Disease, Type 2, Severe Combined Immunodeficiency Due to DCLRE1C Deficiency, Thyroid Dyshormonogenesis 6, Thyroid Dyshormonogenesis 5, Supravalvar Aortic Stenosis, Factor X Deficiency, Hemophilia A, Hemophilia B, Tyrosinemia, Type I, Fructose 1,6 Bisphosphatase Deficiency, Glycogen Storage Disease Type I, G6PD Deficiency, Glycogen Storage Disease II, Galactokinase Deficiency, Mucopolysaccharidosis Type IV A, Galactosemias, Guanidinoacetate Methyltransferase Deficiency, Agat Deficiency, Glutaryl-CoA Dehydrogenase Deficiency, Gtp Cyclohydrolase I Deficiency, Hyperinsulinism-Hyperammonemia Syndrome, Primary Hyperoxaluria Type 2, 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, Sickle Cell Disease, Beta-Thalassemia, Holocarboxylase Synthetase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, Primary Hyperoxaluria Type 3, Hermansky-Pudlak Syndrome 1, Hermansky-Pudlak Syndrome 4, Apparent Mineralocorticoid Excess, HSDB, CBAS1, Mucopolysaccharidosis Type 2, Mucopolysaccharidosis Type 1, Severe Combined Immunodeficiency, X Linked, Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency, Diabetes Mellitus, Permanent Neonatal, Isovaleric Acidemia, Severe Combined Immunodeficiency T-Cell Negative B-Cell Positive Due to Janus Kinase-3 Deficiency (Disorder), Jervell and Lange-Nielsen Syndrome 2, Hyperinsulinemic Hypoglycemia, Familial, 2, Diabetes Mellitus, Permanent Neonatal, With Neurologic Features, Jervell and Lange-Nielsen Syndrome 1, Lysosomal Acid Lipase Deficiency, CblF, 3-Methylcrotonyl CoA Carboxylase 1 Deficiency, 3-Methylcrotonyl CoA Carboxylase 2 Deficiency, Waardenburg Syndrome Type 2A, Methylmalonic Aciduria cblA Type, Methylmalonic Aciduria cblB Type, Methylmalonic Aciduria and Homocystinuria Type cblC, MAHCD, Methylmalonic Aciduria Due to Methylmalonyl-CoA Mutase Deficiency, Congenital Disorder of Glycosylation Type 1B, Mthfr Deficiency, Methylcobalamin Deficiency Type Cbl G (Disorder), Methylcobalamin Deficiency Type cblE, Usher Syndrome, Type 1B, N-acetylglutamate Synthase Deficiency, Ornithine Transcarbamylase Deficiency, Phenylketonurias, Waardenburg Syndrome Type 1, Congenital Hypothyroidism, Propionic Acidemia, Usher Syndrome, Type 1F, Pancreatic Agenesis 1, Hereditary Hypophosphatemic Rickets, Glycogen Storage Disease IXB, Glycogen Storage Disease IXC, MOWS, Epilepsy, Early-Onset, Vitamin B6-Dependent, Pyridoxal Phosphate-Responsive Seizures, Pituitary Hormone Deficiency, Combined, 1, Ptsd, Dihydropteridine Reductase Deficiency, Severe Combined Immunodeficiency Due to RAG1 Deficiency, Severe Combined Immunodeficiency Due to RAG2 Deficiency, Retinoblastoma, Multiple Endocrine Neoplasia Type 2B, Pseudohypoaldosteronism, Type I, Liddle Syndrome, Biotin-Responsive Basal Ganglia Disease, SCD, DIAR1, GSD1C, Acrodermatitis Enteropathica, Thyroid Dyshormonogenesis 1, Riboflavin Transporter Deficiency, Waardenburg Syndrome, Type 2E, SRD, Congenital Lipoid Adrenal Hyperplasia Due to STAR Deficiency, Barth Syndrome, Adrenocorticotropic Hormone Deficiency, Transcobalamin II Deficiency, Thyroid Dyshormonogenesis 3, Segawa Syndrome, Autosomal Recessive, Autosomal Recessive Nonsyndromic Hearing Loss, Thyroid Dyshormonogenesis 2A, Congenital Isolated Thyroid Stimulating Hormone Deficiency, Hypothyroidism Due to TSH Receptor Mutations, Usher Syndrome Type 1C, Usher Syndrome Type 1G (Diagnosis), Von Willebrand Disease, Type 3, Combined Immunodeficiency Due to ZAP70 Deficiency, Adenine Phosphoribosyltransferase Deficiency, Metachromatic Leukodystrophy, Canavan Disease, Menkes Disease, Carbonic Anhydrase VA Deficiency, Developmental and Epileptic Encephalopathy 2, 17 Alpha-Hydroxylase Deficiency, Smith-Lemli-Opitz Syndrome, Krabbe Disease, Glutathione Synthetase Deficiency, Mucopolysaccharidosis Type 7, Rett Syndrome, Molybdenum Cofactor Deficiency, Type A, Niemann-Pick Disease, Type C1, Niemann-Pick Disease Type C2, Ornithine Aminotransferase Deficiency, 3-Phosphoglycerate Dehydrogenase Deficiency, Leber Congenital Amaurosis 2, Dravet Syndrome, Mucopolysaccharidosis Type 3 A, Ornithine Translocase Deficiency, Carnitine-acylcarnitine Translocase Deficiency, Glucose Transporter Type 1 Deficiency Syndrome, Creatine Transporter Deficiency, Niemann-Pick Disease Type A, Pitt Hopkins Syndrome, Tuberous Sclerosis 1, Tuberous Sclerosis 2, Ataxia With Isolated Vitamin E Deficiency, Angelman Syndrome, Prader-Willi Syndrome, Homocystinuria, Permanent Neonatal Diabetes Mellitus, Transient Neonatal Diabetes Mellitus, Factor VII Deficiency, Glycogen Storage Disease Type IXA1, Glycogen Storage Disease, Type IXA2, Glycogen Storage Disease IC, Glycogen Storage Disease Type IB, Central Hypoventilation Syndrome With or Without Hirschsprung Disease",RTI International,2018-10-15,2018-08-31,2024-03-27,2024-10-25T17:03:30.194190
NCT02413450,Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias,ENROLLING_BY_INVITATION,OBSERVATIONAL,,"Inherited Cardiac Arrythmias, Long QT Syndrome (LQTS), Brugada Syndrome (BrS), Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Early Repolarization Syndrome (ERS), Arrhythmogenic Cardiomyopathy (AC, ARVD/C), Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy), Normal Control Subjects",Johns Hopkins University,2013-08,2015-04-10,2024-01-08,2024-10-25T17:03:30.194190
NCT05990608,Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy (DMD),Ondokuz Mayıs University,2021-07-30,2023-08-14,2023-08-14,2024-10-25T17:03:30.194190
NCT06643923,Effects of Lumbopelvic Stabilization-based Physiotherapy and Rehabilitation Training in Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy (DMD), Lower Urinary Track Symptoms",Lokman Hekim Üniversitesi,2024-12-01,2024-10-16,2024-10-16,2024-10-25T17:03:30.194190
NCT05881408,A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2023-05-31,2023-05-31,2024-10-24,2024-10-25T17:03:30.194190
NCT02421523,Strength Training in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Florida,2015-05-30,2015-04-20,2019-03-06,2024-10-25T17:03:30.194190
NCT01335295,Safety Study of Flavocoxid in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,University of Messina,2011-03,2011-04-14,2014-02-03,2024-10-25T17:03:30.194190
NCT05313295,Physical Therapy Treatment on Children and Adolescents With Neurological Pathologies,COMPLETED,INTERVENTIONAL,NA,"Neurologic Disorder, Duchenne, Pediatric Disorder, Sensorimotor Disorder Nos",Universidad de Almeria,2018-11-01,2022-04-06,2023-05-23,2024-10-25T17:03:30.194190
NCT02354781,Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Jerry R. Mendell,2015-01,2015-02-03,2023-10-11,2024-10-25T17:03:30.194190
NCT05559710,Motor Imagery in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2022-06-20,2022-09-29,2023-12-05,2024-10-25T17:03:30.194190
NCT04708314,An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,"Rare Disease Research, LLC",2020-10-31,2021-01-13,2021-05-17,2024-10-25T17:03:30.194190
NCT04240314,AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Megan Waldrop,2020-01-15,2020-01-27,2023-02-09,2024-10-25T17:03:30.194190
NCT03589612,Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Performance, Flexibility",Hacettepe University,2018-03-08,2018-07-18,2019-09-30,2024-10-25T17:03:30.194190
NCT01000012,Compassionate Use of the Becker Expander/Breast Implant,NO_LONGER_AVAILABLE,EXPANDED_ACCESS,,Breast Reconstruction,"Mentor Worldwide, LLC",,2009-10-22,2013-10-29,2024-10-25T17:03:30.194190
NCT04337112,The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation,APPROVED_FOR_MARKETING,EXPANDED_ACCESS,,"Muscular Dystrophy, Duchenne, DMD","NS Pharma, Inc.",,2020-04-07,2020-08-18,2024-10-25T17:03:30.194190
NCT03779646,Bisoprolol in DMD Early Cardiomyopathy,UNKNOWN,INTERVENTIONAL,"PHASE2, PHASE3","Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated",Peking Union Medical College Hospital,2019-01-16,2018-12-19,2022-09-28,2024-10-25T17:03:30.194190
NCT06641895,Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy (DMD),Shanghai Jiao Tong University School of Medicine,2024-07-25,2024-10-15,2024-10-15,2024-10-25T17:03:30.194190
NCT05244395,Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Gait Disorders in Children, Gait Disorders, Neurologic",Hacettepe University,2020-02-10,2022-02-17,2022-03-07,2024-10-25T17:03:30.194190
NCT01521546,Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Subha Raman,2012-02,2012-01-30,2016-11-08,2024-10-25T17:03:30.194190
NCT02515669,"Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD",TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Muscular Dystrophy (DMD),Hoffmann-La Roche,2015-12-02,2015-08-05,2020-11-04,2024-10-25T17:03:30.194190
NCT01856868,Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Becker Muscular Dystrophy,"Craig McDonald, MD",2013-05,2013-05-17,2021-12-22,2024-10-25T17:03:30.194190
NCT01168908,Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",2010-09,2010-07-23,2019-02-26,2024-10-25T17:03:30.194190
NCT05938023,A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Percheron Therapeutics,2023-05-18,2023-07-10,2024-05-30,2024-10-25T17:03:30.194190
NCT02056808,A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Summit Therapeutics,2013-11,2014-02-06,2014-08-27,2024-10-25T17:03:30.194190
NCT02168114,Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Florida,2014-07,2014-06-20,2018-01-12,2024-10-25T17:03:30.194190
NCT03490214,Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy, Duchenne",University of Erlangen-Nürnberg Medical School,2018-06-01,2018-04-06,2019-12-09,2024-10-25T17:03:30.194190
NCT06147414,Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders,NOT_YET_RECRUITING,OBSERVATIONAL,,"Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease, Cystic Fibrosis, Fragile X Syndrome, Proximal Spinal Muscular Atrophy, Myotonic Dystrophy, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Becker, Neurofibromatosis-Noonan Syndrome, Huntington Disease, Hemophilia A, Hemophilia B, MODY2 Diabetes, X-Linked Hydrocephalus, Autosomal Recessive Polycystic Kidney Disease",Assistance Publique - Hôpitaux de Paris,2024-04,2023-11-27,2024-02-28,2024-10-25T17:03:30.194190
NCT05657938,Evaluation of Home Based Assessments on Participants With DMD,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Solid Biosciences Inc.,2022-10-13,2022-12-20,2023-08-14,2024-10-25T17:03:30.194190
NCT06565208,First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy,"Satellos Bioscience, Inc.",2024-08-21,2024-08-21,2024-09-27,2024-10-25T17:03:30.194190
NCT01207908,Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Children's Hospital Medical Center, Cincinnati",2010-11,2010-09-23,2021-01-20,2024-10-25T17:03:30.194190
NCT05016908,Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Massachusetts General Hospital,2019-11-30,2021-08-23,2023-10-12,2024-10-25T17:03:30.194190
NCT05274555,Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Extremity Problem",Dokuz Eylul University,2019-03-27,2022-03-10,2022-06-09,2024-10-25T17:03:30.194190
NCT03167255,Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2017-07-06,2017-05-25,2022-12-28,2024-10-25T17:03:30.194190
NCT01128855,"A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects",COMPLETED,INTERVENTIONAL,PHASE1,Muscular Dystrophies,GlaxoSmithKline,2010-07-12,2010-05-24,2017-07-18,2024-10-25T17:03:30.194190
NCT01491555,Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Boston Children's Hospital,2012-04,2011-12-14,2016-03-24,2024-10-25T17:03:30.194190
NCT03375255,"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)",COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2018-02-05,2017-12-18,2022-07-06,2024-10-25T17:03:30.194190
NCT03372655,Prognostic Factors Affecting Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Assiut University,2018-01-01,2017-12-14,2017-12-14,2024-10-25T17:03:30.194190
NCT01066455,Cardiac Outcome Measures in Children With Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy",Cooperative International Neuromuscular Research Group,2010-01,2010-02-10,2013-01-11,2024-10-25T17:03:30.194190
NCT02834650,Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne",Stanford University,2017-02-01,2016-07-15,2022-05-10,2024-10-25T17:03:30.194190
NCT02835079,Treatment Effect of Tamoxifen on Patients With DMD,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Hadassah Medical Organization,2016-11,2016-07-15,2022-07-25,2024-10-25T17:03:30.194190
NCT02340923,"A Device for Rapid, Painless, Bedside Muscle Evaluation of Children",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Skulpt, Inc.",2015-01,2015-01-19,2016-08-11,2024-10-25T17:03:30.194190
NCT05409079,Schulze Muscular Dystrophy Ability Clinical Study,RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophies, Spinal Muscular Atrophy, Duchenne Muscular Dystrophy, Limb Girdle Muscular Dystrophy, FSHD, Cerebral Palsy, Becker Muscular Dystrophy",AbiliTech Medical Inc.,2022-05-26,2022-06-08,2022-12-05,2024-10-25T17:03:30.194190
NCT02891434,Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Sao Paulo,2016-02,2016-09-07,2017-04-11,2024-10-25T17:03:30.194190
NCT00033813,KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2002-01,2002-04-11,2014-03-10,2024-10-25T17:03:30.194190
NCT06079736,A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PepGen Inc,2024-01-08,2023-10-12,2024-05-13,2024-10-25T17:03:30.194190
NCT04060199,Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53),COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2020-04-14,2019-08-19,2023-10-27,2024-10-25T17:03:30.194190
NCT05549999,"Cultural Adaptation, Validity, and Reliability of the Turkish Version of North Star Ambulatory Assessment",COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Ambulation Difficulty, Ambulation Disorder, Neurologic",Hacettepe University,2022-11-01,2022-09-22,2023-07-28,2024-10-25T17:03:30.194190
NCT05338099,Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,ENCell,2022-01-18,2022-04-20,2024-08-30,2024-10-25T17:03:30.194190
NCT02195999,Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",University of Florida,2013-12,2014-07-21,2019-07-08,2024-10-25T17:03:30.194190
NCT03038399,Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2017-02-02,2017-01-31,2021-05-20,2024-10-25T17:03:30.194190
NCT03532542,An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2018-08-02,2018-05-22,2024-09-19,2024-10-25T17:03:30.194190
NCT02310906,Phase I/II Study of SRP-4053 in DMD Patients,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2015-01-13,2014-12-08,2020-10-19,2024-10-25T17:03:30.194190
NCT01286870,Becker Continued Access Study,TERMINATED,INTERVENTIONAL,PHASE4,Breast Reconstruction,"Mentor Worldwide, LLC",2009-06-01,2011-01-31,2019-03-06,2024-10-25T17:03:30.194190
NCT05195775,Tadalafil as Adjuvant Therapy for DMD,RECRUITING,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,University of Florida,2021-12-14,2022-01-19,2024-01-31,2024-10-25T17:03:30.194190
NCT03951675,The Burden of Access in Duchenne Muscular Dystrophy in the US,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Florida,2019-06-18,2019-05-15,2020-08-06,2024-10-25T17:03:30.194190
NCT01359670,Tadalafil and Sildenafil for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy,Cedars-Sinai Medical Center,2011-05,2011-05-25,2020-01-14,2024-10-25T17:03:30.194190
NCT04335942,Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy",Assistance Publique - Hôpitaux de Paris,2021-09-30,2020-04-07,2023-08-31,2024-10-25T17:03:30.194190
NCT06402942,Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Gamification, Occupational Therapy",Başak Çağla Arslan,2024-09-01,2024-05-07,2024-07-18,2024-10-25T17:03:30.194190
NCT01519349,Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis,COMPLETED,INTERVENTIONAL,PHASE1,"Becker Muscular Dystrophy, Sporadic Inclusion Body Myositis",Nationwide Children's Hospital,2012-01,2012-01-26,2023-10-02,2024-10-25T17:03:30.194190
NCT02789059,Muscle Oxygenation in Effort in Neuromuscular Diseases,UNKNOWN,INTERVENTIONAL,NA,Neuromuscular Diseases,"University Hospital, Lille",2015-07-02,2016-06-02,2017-05-19,2024-10-25T17:03:30.194190
NCT06379906,"Upper Extremity Muscle Strength, Balance and Functional Skills in DMD",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Halic University,2023-11-10,2024-04-23,2024-04-25,2024-10-25T17:03:30.194190
NCT06103006,Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Lokman Hekim Üniversitesi,2021-01-01,2023-10-26,2023-10-27,2024-10-25T17:03:30.194190
NCT01557400,"Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada",COMPLETED,INTERVENTIONAL,PHASE3,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Dystrophinopathy",PTC Therapeutics,2012-05-20,2012-03-19,2020-11-25,2024-10-25T17:03:30.194190
NCT06579859,Development of a Registry to Assess Natural History in Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,2024-11-01,2024-08-30,2024-08-30,2024-10-25T17:03:30.194190
NCT06579352,Expanded Access Study of UC-MSC in DMD Patients,AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,MED Institute Inc.,,2024-08-30,2024-08-30,2024-10-25T17:03:30.194190
NCT01712152,Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study,COMPLETED,OBSERVATIONAL,,Carrier of Duchenne Muscular Dystrophy,Hospital Rudolfstiftung,2012-10,2012-10-23,2016-10-04,2024-10-25T17:03:30.194190
NCT00468832,Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD),UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2005-12,2007-05-03,2016-04-21,2024-10-25T17:03:30.194190
NCT01995032,L-citrulline and Metformin in Duchenne's Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne's Muscular Dystrophy (DMD),"University Hospital, Basel, Switzerland",2013-10,2013-11-26,2018-04-19,2024-10-25T17:03:30.194190
NCT05029232,Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital,UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Sohag University,2021-10-01,2021-08-31,2021-08-31,2024-10-25T17:03:30.194190
NCT01422200,Flu Vaccine Study in Neuromuscular Patients 2011,COMPLETED,INTERVENTIONAL,PHASE4,"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Congenital Muscular Dystrophy","Children's Hospital Medical Center, Cincinnati",2011-08,2011-08-23,2020-10-19,2024-10-25T17:03:30.194190
NCT02354352,Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Ohio State University,2015-03-20,2015-02-03,2019-10-07,2024-10-25T17:03:30.194190
NCT01197300,1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids,COMPLETED,INTERVENTIONAL,PHASE3,Osteoporosis,Novartis Pharmaceuticals,2010-10-25,2010-09-09,2019-09-20,2024-10-25T17:03:30.194190
NCT03836300,Parent and Infant Inter(X)Action Intervention (PIXI),ENROLLING_BY_INVITATION,INTERVENTIONAL,NA,"Fragile X Syndrome, Angelman Syndrome, Prader-Willi Syndrome, Dup15Q Syndrome, Duchenne Muscular Dystrophy, Phelan-McDermid Syndrome, Rett Syndrome, Smith Magenis Syndrome, Williams Syndrome, Turner Syndrome, Klinefelter Syndrome, Chromosome 22q11.2 Deletion Syndrome, Tuberous Sclerosis, Down Syndrome",RTI International,2018-11-30,2019-02-11,2024-05-01,2024-10-25T17:03:30.194190
NCT01386515,The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD),TERMINATED,OBSERVATIONAL,,"Genetic Disease, Communication",National Human Genome Research Institute (NHGRI),2011-06-07,2011-07-01,2019-12-12,2024-10-25T17:03:30.194190
NCT04193085,Wearable Technology to Assess Gait Function in SMA and DMD,COMPLETED,OBSERVATIONAL,,"Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy",Columbia University,2019-11-25,2019-12-10,2024-09-23,2024-10-25T17:03:30.194190
NCT05110885,"Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices",UNKNOWN,OBSERVATIONAL,,"Spinal Muscular Atrophy, Duchenne Muscular Dystrophy, Healthy Individuals",Bahçeşehir University,2021-11,2021-11-08,2021-11-10,2024-10-25T17:03:30.194190
NCT04281485,Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Pfizer,2020-11-05,2020-02-24,2024-09-19,2024-10-25T17:03:30.194190
NCT05160415,A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2021-12-28,2021-12-16,2024-06-14,2024-10-25T17:03:30.194190
NCT06445985,Hydrotherapy in Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Lancashire Teaching Hospitals NHS Foundation Trust,2022-11-02,2024-06-06,2024-06-06,2024-10-25T17:03:30.194190
NCT03443115,Duchenne Muscular Dystrophy Heart Study,UNKNOWN,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy",Hôpital Cochin,2017-06-27,2018-02-22,2018-02-22,2024-10-25T17:03:30.194190
NCT02516085,Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"University Hospital, Basel, Switzerland",2012-01,2015-08-05,2015-08-07,2024-10-25T17:03:30.194190
NCT02432885,Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial,COMPLETED,INTERVENTIONAL,PHASE3,"Myocardial Fibrosis, Muscular Dystrophies",InCor Heart Institute,2009-06,2015-05-04,2015-05-04,2024-10-25T17:03:30.194190
NCT01037309,Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2009-12,2009-12-23,2018-10-16,2024-10-25T17:03:30.194190
NCT03400852,A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Mallinckrodt ARD LLC,2018-07-27,2018-01-17,2021-03-16,2024-10-25T17:03:30.194190
NCT06093100,Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Vanderbilt University Medical Center,2024-07-10,2023-10-23,2024-09-19,2024-10-25T17:03:30.194190
NCT00750685,Study of the Mentor Becker Expander/Breast Implant in Subjects Who Are Undergoing Primary Breast Reconstruction,TERMINATED,INTERVENTIONAL,PHASE3,Breast Reconstruction,"Mentor Worldwide, LLC",2007-03-01,2008-09-10,2018-05-08,2024-10-25T17:03:30.194190
NCT01981915,Optimum Insufflation Capacity in NMD,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Chronic Respiratory Insufficiency",Universität Duisburg-Essen,2011-01,2013-11-13,2013-11-13,2024-10-25T17:03:30.194190
NCT06366815,phenotypeS in Non Ambulant Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Natural History, Motor Function; Retardation",Fondazione Policlinico Universitario Agostino Gemelli IRCCS,2022-08-30,2024-04-16,2024-10-04,2024-10-25T17:03:30.194190
NCT02255552,Study of Eteplirsen in DMD Patients,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy (DMD),"Sarepta Therapeutics, Inc.",2014-11-17,2014-10-02,2021-01-25,2024-10-25T17:03:30.194190
NCT02251600,A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,PTC Therapeutics,2014-12,2014-09-29,2017-08-18,2024-10-25T17:03:30.194190
NCT05693142,AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,REGENXBIO Inc.,2023-01-04,2023-01-20,2024-07-23,2024-10-25T17:03:30.194190
NCT06643442,Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age,NOT_YET_RECRUITING,INTERVENTIONAL,PHASE2,DMD-associated Dilated Cardiomyopathy,Sebastiano Lava,2025-02-01,2024-10-16,2024-10-16,2024-10-25T17:03:30.194190
NCT05514249,Treatment of a Single Patient With CRD-TMH-001,UNKNOWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Cure Rare Disease, Inc",2022-08-31,2022-08-24,2022-09-01,2024-10-25T17:03:30.194190
NCT03368742,Microdystrophin Gene Transfer Study in Adolescents and Children With DMD,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Solid Biosciences Inc.,2017-12-06,2017-12-11,2024-10-15,2024-10-25T17:03:30.194190
NCT01153932,Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Muscular Dystrophies,GlaxoSmithKline,2010-09,2010-06-30,2014-08-25,2024-10-25T17:03:30.194190
NCT03057002,UTSW HP [13-C] Pyruvate Injection in HCM,RECRUITING,OBSERVATIONAL,,"Cardiomyopathy, Hypertrophic, Dilated Cardiomyopathy, Duchenne Muscular Dystrophy, Cardiac Sarcoidosis, Becker Muscular Dystrophy, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction",University of Texas Southwestern Medical Center,2018-05-01,2017-02-17,2024-02-05,2024-10-25T17:03:30.194190
NCT01865084,A Study of Tadalafil for Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",Eli Lilly and Company,2013-09,2013-05-30,2019-10-09,2024-10-25T17:03:30.194190
NCT03335384,Relationship Between PFTs and Pdi in DMD,WITHDRAWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Minnesota,2018-05-01,2017-11-07,2018-05-14,2024-10-25T17:03:30.194190
NCT01027884,Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Ambulatory Care",Santhera Pharmaceuticals,2009-07,2009-12-09,2015-10-19,2024-10-25T17:03:30.194190
NCT02420379,Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),"Sarepta Therapeutics, Inc.",2015-06-30,2015-04-17,2021-01-25,2024-10-25T17:03:30.194190
NCT03362502,A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Pfizer,2018-01-23,2017-12-05,2024-09-20,2024-10-25T17:03:30.194190
NCT02958202,Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2016-04,2016-11-08,2018-01-26,2024-10-25T17:03:30.194190
NCT01523964,DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Dart Therapeutics. LLC,2012-02,2012-02-01,2013-12-09,2024-10-25T17:03:30.194190
NCT01388764,"Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids",COMPLETED,INTERVENTIONAL,PHASE1,"Dystrophinopathy, Duchenne Muscular Dystrophy, Becker's Muscular Dystrophy",Massachusetts General Hospital,2012-01,2011-07-07,2012-07-03,2024-10-25T17:03:30.194190
NCT05689164,A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.,RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Pfizer,2023-03-13,2023-01-19,2024-02-22,2024-10-25T17:03:30.194190
NCT02472990,Biomechanical and Morphological Changes in Dystrophic Muscle,UNKNOWN,INTERVENTIONAL,NA,Duchenne Dystrophy Muscular,"University Hospital, Brest",2015-07,2015-06-16,2018-03-16,2024-10-25T17:03:30.194190
NCT01380964,Research of Biomarkers in Duchenne Muscular Dystrophy Patients,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy (DMD),Genethon,2011-06,2011-06-27,2016-08-17,2024-10-25T17:03:30.194190
NCT06128564,A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Hoffmann-La Roche,2023-11-29,2023-11-13,2024-10-22,2024-10-25T17:03:30.194190
NCT00674843,The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies,UNKNOWN,INTERVENTIONAL,PHASE1,Muscular Dystrophies,GAAD Medical Research Institute Inc.,2008-05,2008-05-08,2009-08-17,2024-10-25T17:03:30.194190
NCT04585464,"A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults",COMPLETED,INTERVENTIONAL,PHASE1,"Healthy Volunteer, Becker Muscular Dystrophy","Edgewise Therapeutics, Inc.",2020-10-12,2020-10-14,2022-06-28,2024-10-25T17:03:30.194190
NCT06304064,Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Capricor Inc.,2018-06-21,2024-03-12,2024-04-24,2024-10-25T17:03:30.194190
NCT00296621,Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Assistance Publique - Hôpitaux de Paris,2006-02,2006-02-27,2007-12-21,2024-10-25T17:03:30.194190
NCT03375164,A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2018-01-04,2017-12-15,2024-05-23,2024-10-25T17:03:30.194190
NCT02525302,HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Akashi Therapeutics,2015-05,2015-08-17,2019-03-12,2024-10-25T17:03:30.194190
NCT05096221,A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2021-10-27,2021-10-27,2023-11-07,2024-10-25T17:03:30.194190
NCT01918384,"Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy",UNKNOWN,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Kobe University,2013-08,2013-08-07,2015-09-03,2024-10-25T17:03:30.194190
NCT02485938,HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Duchenne Muscular Dystrophy, Cardiomyopathy",Capricor Inc.,2016-01,2015-06-30,2018-07-20,2024-10-25T17:03:30.194190
NCT03333590,Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Kevin Flanigan,2017-11-06,2017-11-07,2023-09-14,2024-10-25T17:03:30.194190
NCT02760264,A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2016-06,2016-05-03,2019-01-02,2024-10-25T17:03:30.194190
NCT05996003,NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2024-02-22,2023-08-16,2024-03-29,2024-10-25T17:03:30.194190
NCT00847379,Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD),TERMINATED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",PTC Therapeutics,2009-01-31,2009-02-19,2020-07-15,2024-10-25T17:03:30.194190
NCT05683379,AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,REGENXBIO Inc.,2022-12-20,2023-01-13,2024-07-18,2024-10-25T17:03:30.194190
NCT00654784,Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),Santhera Pharmaceuticals,2005-10,2008-04-09,2011-08-01,2024-10-25T17:03:30.194190
NCT06114056,"A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)",RECRUITING,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,West China Hospital,2024-01-22,2023-11-02,2024-01-17,2024-10-25T17:03:30.194190
NCT01125709,Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS),COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2010-01,2010-05-18,2013-01-11,2024-10-25T17:03:30.194190
NCT05166109,A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD),RECRUITING,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2022-07-07,2021-12-21,2024-08-19,2024-10-25T17:03:30.194190
NCT03531788,Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD,TERMINATED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Roxanna Marie Bendixen,2018-08-30,2018-05-22,2022-02-18,2024-10-25T17:03:30.194190
NCT04529707,Sleep Intervention in Young Boys With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Pittsburgh,2021-02-17,2020-08-28,2024-03-05,2024-10-25T17:03:30.194190
NCT06597656,A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74,RECRUITING,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2024-09-18,2024-09-19,2024-10-16,2024-10-25T17:03:30.194190
NCT01247207,Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD),ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,PTC Therapeutics,2010-11-30,2010-11-24,2024-10-09,2024-10-25T17:03:30.194190
NCT03433807,Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD),NO_LONGER_AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,,2018-02-15,2023-04-21,2024-10-25T17:03:30.194190
NCT01603407,Finding the Optimum Regimen for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,University of Rochester,2013-01,2012-05-23,2022-08-12,2024-10-25T17:03:30.194190
NCT03796637,A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2019-04-11,2019-01-08,2022-04-05,2024-10-25T17:03:30.194190
NCT05209087,Effects of Parental Influence on Physical Activity Level and Participation in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",Hacettepe University,2020-03-01,2022-01-26,2022-09-09,2024-10-25T17:03:30.194190
NCT05066633,The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD,RECRUITING,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",Medical University of Gdansk,2021-08-18,2021-10-04,2021-10-04,2024-10-25T17:03:30.194190
NCT06100887,Phase 2 Study of EDG-5506 in Children and Adolescents with Duchenne Muscular Dystrophy Previously Treated with Gene Therapy (FOX),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2024-03-22,2023-10-25,2024-09-19,2024-10-25T17:03:30.194190
NCT02439216,Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne",Catabasis Pharmaceuticals,2016-04,2015-05-08,2022-09-23,2024-10-25T17:03:30.194190
NCT01874275,Duchenne Muscular Dystrophy Clinical Trial,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,"Alan Neuromedical Technologies, LLC",2013-06,2013-06-11,2015-05-04,2024-10-25T17:03:30.194190
NCT03439670,A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2018-06-29,2018-02-20,2023-03-09,2024-10-25T17:03:30.194190
NCT02847975,Sodium Nitrate to Improve Blood Flow,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2013-10,2016-07-28,2018-08-06,2024-10-25T17:03:30.194190
NCT00606775,The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,PHASE4,"Duchenne Muscular Dystrophy, Cardiomyopathies",Suzuka Hospital,2007-12,2008-02-05,2008-02-05,2024-10-25T17:03:30.194190
NCT01999075,Stacking Exercises Aid the Decline in FVC and Sick Time,COMPLETED,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Children's Hospital of Eastern Ontario,2013-03,2013-12-03,2018-12-24,2024-10-25T17:03:30.194190
NCT03603288,Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E),TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2018-07-04,2018-07-27,2021-12-03,2024-10-25T17:03:30.194190
NCT06054971,NSAA NON-Interventional Study Protocol,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Red Nucleus Enterprise Solutions, LLC",2023-10-02,2023-09-26,2023-11-22,2024-10-25T17:03:30.194190
NCT00104078,Study Evaluating MYO-029 in Adult Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophy",Wyeth is now a wholly owned subsidiary of Pfizer,2005-02,2005-02-23,2007-12-28,2024-10-25T17:03:30.194190
NCT05849688,Bicycle Training on Ventilatory Functions in Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Beni-Suef University,2023-05-15,2023-05-09,2023-05-09,2024-10-25T17:03:30.194190
NCT00264888,Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2005-12,2005-12-13,2009-01-14,2024-10-25T17:03:30.194190
NCT06280209,"A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2024-01-03,2024-02-28,2024-06-18,2024-10-25T17:03:30.194190
NCT04179409,"A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Kevin Flanigan,2020-02-18,2019-11-27,2023-10-26,2024-10-25T17:03:30.194190
NCT00018109,A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",National Center for Research Resources (NCRR),,2001-07-05,2005-06-24,2024-10-25T17:03:30.194190
NCT02069756,The Duchenne Registry,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",The Duchenne Registry,2007-10,2014-02-24,2023-09-13,2024-10-25T17:03:30.194190
NCT01540409,"Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),"Sarepta Therapeutics, Inc.",2012-02-27,2012-02-28,2020-03-30,2024-10-25T17:03:30.194190
NCT03985878,"A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2019-06-26,2019-06-14,2023-08-18,2024-10-25T17:03:30.194190
NCT01484678,Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",University of Florida,2020-09-01,2011-12-02,2024-07-24,2024-10-25T17:03:30.194190
NCT02246478,A Study of TAS-205 for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2014-09,2014-09-22,2021-06-04,2024-10-25T17:03:30.194190
NCT03521271,Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2017-04-05,2018-05-11,2018-05-11,2024-10-25T17:03:30.194190
NCT01070511,Tadalafil in Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE4,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2010-01,2010-02-18,2013-08-20,2024-10-25T17:03:30.194190
NCT04012671,A Registered Cohort Study on Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Ning Wang, MD., PhD.",2019-07-01,2019-07-09,2021-03-22,2024-10-25T17:03:30.194190
NCT05661071,Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2022-05-11,2022-12-22,2022-12-22,2024-10-25T17:03:30.194190
NCT05967793,Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Egyptian Chinese University,2023-07,2023-08-01,2023-08-01,2024-10-25T17:03:30.194190
NCT06274983,DMD- Interactive Virtual Reality Study,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Sheffield Children's NHS Foundation Trust,2023-04-20,2024-02-23,2024-02-26,2024-10-25T17:03:30.194190
NCT02383511,Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",Summit Therapeutics,2015-02,2015-03-09,2015-08-26,2024-10-25T17:03:30.194190
NCT01126697,Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3","Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy",Cooperative International Neuromuscular Research Group,2010-02,2010-05-20,2018-06-15,2024-10-25T17:03:30.194190
NCT02667483,Study of DS-5141b in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Daiichi Sankyo Co., Ltd.",2015-10,2016-01-29,2024-03-07,2024-10-25T17:03:30.194190
NCT00844597,Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2009-01,2009-02-16,2015-10-06,2024-10-25T17:03:30.194190
NCT01963897,"Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Oslo University Hospital,2013-08,2013-10-16,2017-09-25,2024-10-25T17:03:30.194190
NCT05641805,Physical Activity Level and Cognitive Functions in Children With Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Muş Alparlan University,2022-11-29,2022-12-08,2023-02-09,2024-10-25T17:03:30.194190
NCT02851797,Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Italfarmaco,2017-06-06,2016-08-02,2023-02-02,2024-10-25T17:03:30.194190
NCT02530905,Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2015-10-08,2015-08-21,2021-05-17,2024-10-25T17:03:30.194190
NCT02034305,Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Pittsburgh,2014-01,2014-01-13,2024-02-05,2024-10-25T17:03:30.194190
NCT02571205,Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Newcastle-upon-Tyne Hospitals NHS Trust,2015-11,2015-10-08,2021-04-13,2024-10-25T17:03:30.194190
NCT06412328,Psychoeducation Program for Parents of Children With DMD,COMPLETED,INTERVENTIONAL,NA,"Psychoeducation, Parents, Psychological Wellness, Duchenne Muscular Dystrophy",Lokman Hekim Üniversitesi,2023-06-21,2024-05-14,2024-05-14,2024-10-25T17:03:30.194190
NCT02810028,Acceptance and Commitment Therapy for Muscle Disease,COMPLETED,INTERVENTIONAL,NA,Muscle Diseases,King's College Hospital NHS Trust,2016-07,2016-06-22,2019-08-22,2024-10-25T17:03:30.194190
NCT05249361,Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Samsung Medical Center,2023-05-01,2022-02-21,2023-11-29,2024-10-25T17:03:30.194190
NCT00720161,Metformin in Children With Motor Deficit,COMPLETED,INTERVENTIONAL,NA,"Spina Bifida, Neuromuscular Diseases",Universitaire Ziekenhuizen KU Leuven,2006-11,2008-07-22,2024-06-17,2024-10-25T17:03:30.194190
NCT06485661,Effect of Captopril on GLS in Duchenne Myodystrophy,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Effect of Drug,Ain Shams University,2024-01-01,2024-07-03,2024-07-16,2024-10-25T17:03:30.194190
NCT00016653,Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3","Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2000-06,2001-05-23,2011-10-27,2024-10-25T17:03:30.194190
NCT03963453,Regular Physical Exercise in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",Haukeland University Hospital,2021-02-01,2019-05-24,2023-03-01,2024-10-25T17:03:30.194190
NCT02760277,An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2016-07-28,2016-05-03,2019-07-23,2024-10-25T17:03:30.194190
NCT02286947,Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2014-11,2014-11-10,2020-03-30,2024-10-25T17:03:30.194190
NCT02653833,The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy,TERMINATED,INTERVENTIONAL,EARLY_PHASE1,Muscular Dystrophy,Cedars-Sinai Medical Center,2017-11-01,2016-01-12,2020-01-14,2024-10-25T17:03:30.194190
NCT04740554,Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Sao Paulo,2013-03-01,2021-02-05,2021-02-05,2024-10-25T17:03:30.194190
NCT02020954,Prospective Becker-Heart-Study,UNKNOWN,OBSERVATIONAL,,"Dilated Cardiomyopathy, Lef Ventricular Dysfunction, Heart Failure",Karim WAHBI,2013-01,2013-12-25,2015-03-24,2024-10-25T17:03:30.194190
NCT01826487,Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2013-03-26,2013-04-08,2020-08-04,2024-10-25T17:03:30.194190
NCT01823783,"Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy",UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Distrophy (DMD),"University Hospital, Montpellier",2012-11-07,2013-04-04,2020-02-07,2024-10-25T17:03:30.194190
NCT05524883,"Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping",RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Dyne Therapeutics,2022-08-12,2022-09-01,2024-10-24,2024-10-25T17:03:30.194190
NCT03642145,A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD),WITHDRAWN,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,PTC Therapeutics,2018-10-31,2018-08-22,2019-06-21,2024-10-25T17:03:30.194190
NCT05712447,Duchenne Muscular Dystrophy Video Assessment Registry,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"The Emmes Company, LLC",2022-09-01,2023-02-03,2023-12-18,2024-10-25T17:03:30.194190
NCT03002298,Virtual Reality in Individuals With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Sao Paulo,2016-01,2016-12-23,2017-04-11,2024-10-25T17:03:30.194190
NCT01890798,Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol,WITHDRAWN,INTERVENTIONAL,PHASE3,Muscular Dystrophies,GlaxoSmithKline,2014-01,2013-07-02,2014-03-24,2024-10-25T17:03:30.194190
NCT01645098,Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Nationwide Children's Hospital,2011-08,2012-07-20,2015-02-26,2024-10-25T17:03:30.194190
NCT00592553,Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD),COMPLETED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",PTC Therapeutics,2008-02-29,2008-01-14,2020-04-07,2024-10-25T17:03:30.194190
NCT00102453,Pentoxifylline in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2002-03,2005-01-31,2011-10-27,2024-10-25T17:03:30.194190
NCT02964377,Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Craig McDonald, MD",2016-11,2016-11-16,2021-12-21,2024-10-25T17:03:30.194190
NCT03508947,Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2018-01-24,2018-04-26,2019-04-08,2024-10-25T17:03:30.194190
NCT01480245,Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,Muscular Dystrophies,GlaxoSmithKline,2011-09,2011-11-28,2017-03-23,2024-10-25T17:03:30.194190
NCT05516745,"E-monitoring of PULMonary Function in Patients With Duchenne Muscular Dystrophy at Home""",RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy (DMD),Medical University of Gdansk,2021-03-20,2022-08-26,2022-08-26,2024-10-25T17:03:30.194190
NCT04669847,The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne, Upper Extremity, Respiratory Functions",Gokce Yagmur Gunes Gencer,2018-04-07,2020-12-17,2020-12-17,2024-10-25T17:03:30.194190
NCT00819845,Ramipril Versus Carvedilol in Duchenne and Becker Patients,UNKNOWN,INTERVENTIONAL,PHASE4,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","Catholic University, Italy",2008-12,2009-01-09,2016-01-28,2024-10-25T17:03:30.194190
NCT00312247,Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Shriners Hospitals for Children,2006-04,2006-04-07,2015-05-19,2024-10-25T17:03:30.194190
NCT01099761,Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",2010-04,2010-04-08,2022-10-13,2024-10-25T17:03:30.194190
NCT05967351,A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study,ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2023-09-27,2023-08-01,2024-10-21,2024-10-25T17:03:30.194190
NCT01350154,"Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients",COMPLETED,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Rigshospitalet, Denmark",2011-11,2011-05-09,2013-04-10,2024-10-25T17:03:30.194190
NCT04384354,Digestive Events in Duchenne Muscular Dystrophy Patients,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Centre d'Investigation Clinique et Technologique 805,2007-01,2020-05-12,2020-05-12,2024-10-25T17:03:30.194190
NCT00839033,Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders,TERMINATED,INTERVENTIONAL,PHASE3,"Duchenne Muscular Dystrophy, Amyotrophic Lateral Sclerosis, Neuromuscular Diseases",Assistance Publique - Hôpitaux de Paris,2009-06,2009-02-09,2015-05-28,2024-10-25T17:03:30.194190
NCT05833633,Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations,RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",Fondazione Policlinico Universitario Agostino Gemelli IRCCS,2022-03-18,2023-04-27,2023-05-15,2024-10-25T17:03:30.194190
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-25T17:03:50.848735
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-25T17:03:50.848735
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-25T17:03:50.848735
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-25T17:03:50.848735
NCT03589573,Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Muscle Strength, Lower Extremity, Hamstring Contractures",Hacettepe University,2017-03-24,2018-07-18,2018-07-31,2024-10-25T17:03:50.848735
NCT01633866,Pediatric Radio Frequency Coils Generic,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Musculoskeletal Abnormalities","Children's Hospital Medical Center, Cincinnati",2012-07,2012-07-04,2023-09-28,2024-10-25T17:03:50.848735
NCT06491927,Long Term Follow-up for RGX-202,ENROLLING_BY_INVITATION,OBSERVATIONAL,,Duchenne Muscular Dystrophy,REGENXBIO Inc.,2024-05-08,2024-07-09,2024-07-09,2024-10-25T17:03:50.848735
NCT01931644,"At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions",COMPLETED,OBSERVATIONAL,,"All Diagnosed Health Conditions, ADD/ADHD, Alopecia Areata, Ankylosing Spondylitis, Asthma, Atopic Dermatitis Eczema, Beta Thalassemia, Bipolar Disorder, Breast Cancer, Celiac Disease, Cervical Cancer, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Colon Cancer, Colorectal Cancer, Crohn's Disease, Cystic Fibrosis, Depression, Diabetes Mellitus, Duchenne Muscular Dystrophy, Endometriosis, Epilepsy, Facioscapulohumeral Muscular Dystrophy, G6PD Deficiency, General Anxiety Disorder, Hepatitis B, Hereditary Hemorrhagic Telangiectasia, HIV/AIDS, Human Papilloma Virus, Huntington's Disease, Idiopathic Thrombocytopenic Purpura, Insomnia, Kidney Cancer, Leukemia, Lung Cancer, Lupus Nephritis, Lymphoma, Melanoma, Multiple Myeloma, Multiple Sclerosis, Myositis, Myotonic Dystrophy, Ovarian Cancer, Pancreatic Cancer, Parkinson's Disease, Polycystic Kidney Diseases, Prostate Cancer, Psoriasis, Psoriatic Arthritis, Rosacea, Scleroderma, Sickle Cell Anemia, Sickle Cell Trait, Sjogren's Syndrome, Skin Cancer, Spinal Muscular Atrophy, Systemic Lupus Erythematosus, Thrombotic Thrombocytopenic Purpura, Trisomy 21, Ulcerative Colitis",Sanguine Biosciences,2013-07,2013-08-29,2024-04-18,2024-10-25T17:03:50.848735
NCT03611244,Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device,RECRUITING,INTERVENTIONAL,NA,"Scoliosis Neuromuscular, Duchenne Muscular Dystrophy, Lordosis Lumbar",Seoul National University Hospital,2018-08-07,2018-08-02,2018-09-18,2024-10-25T17:03:50.848735
NCT02780492,Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"University College, London",2012-04-11,2016-05-23,2024-01-05,2024-10-25T17:03:50.848735
NCT00873782,Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophies, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy","University of North Carolina, Chapel Hill",2009-03,2009-04-02,2015-03-09,2024-10-25T17:03:50.848735
NCT03680365,Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Burden, Dependency, Disability Physical, Disease Management, Impairment, Rare Diseases","Jett Foundation, Inc.",2018-09-20,2018-09-21,2019-04-01,2024-10-25T17:03:50.848735
NCT02436720,Upper Limb Assessment in Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Catholic University of the Sacred Heart,2013-01,2015-05-07,2015-05-07,2024-10-25T17:03:50.848735
NCT06564974,Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy.,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Catalyst Pharmaceuticals, Inc.",2024-07-31,2024-08-21,2024-10-23,2024-10-25T17:03:50.848735
NCT03633565,Comparative Study of Strategies for Management of Duchenne Myopathy (DM),UNKNOWN,INTERVENTIONAL,PHASE4,Myopathy,Assiut University,2018-09,2018-08-16,2018-08-16,2024-10-25T17:03:50.848735
NCT00005574,Gentamicin Treatment of Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Becker Muscular Dystrophy, Duchenne Muscular Dystrophy",National Institute of Neurological Disorders and Stroke (NINDS),2000-02,2002-12-10,2008-03-04,2024-10-25T17:03:50.848735
NCT01826474,Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2013-01,2013-04-08,2017-12-08,2024-10-25T17:03:50.848735
NCT03675126,An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen),TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2018-12-19,2018-09-18,2024-09-19,2024-10-25T17:03:50.848735
NCT06363526,Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Muscular Dystrophy",University of Malaga,2024-05-05,2024-04-12,2024-04-12,2024-10-25T17:03:50.848735
NCT00207857,Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy,WITHDRAWN,OBSERVATIONAL,,"Duchenne's Muscular Dystrophy, Scoliosis",Children's Healthcare of Atlanta,2004-03,2005-09-21,2015-02-04,2024-10-25T17:03:50.848735
NCT04322357,Twice Weekly Steroids and Exercise as Therapy for DMD,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),University of Florida,2020-07-30,2020-03-26,2024-01-31,2024-10-25T17:03:50.848735
NCT06363357,"The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne, Orthotic Devices, Upper Extremity",Seoul National University Hospital,2024-04-20,2024-04-12,2024-06-21,2024-10-25T17:03:50.848735
NCT05715957,Follow-up Study on Female Carriers With DMD Gene Variants,NOT_YET_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","Rigshospitalet, Denmark",2023-03-01,2023-02-08,2023-02-09,2024-10-25T17:03:50.848735
NCT03552874,Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Limb Function, Respiratory Function Test",Hacettepe University,2017-01-01,2018-06-12,2018-06-12,2024-10-25T17:03:50.848735
NCT04349566,Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases,COMPLETED,OBSERVATIONAL,,"Becker Muscular Dystrophy, McArdle Disease, Limb-Girdle Muscular Dystrophy Type 2",Mads Peter Godtfeldt Stemmerik,2020-06-01,2020-04-16,2022-10-27,2024-10-25T17:03:50.848735
NCT01921374,Mother-caregivers of Children With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Other Diseases or Conditions,Monica Levy Andersen,2013-08,2013-08-13,2016-02-03,2024-10-25T17:03:50.848735
NCT04626674,A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-11-23,2020-11-12,2024-08-26,2024-10-25T17:03:50.848735
NCT00451074,Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Nationwide Children's Hospital,2007-03,2007-03-23,2012-03-23,2024-10-25T17:03:50.848735
NCT04287582,The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2019-04-03,2020-02-27,2020-02-27,2024-10-25T17:03:50.848735
NCT01847573,"Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy",TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Processa Pharmaceuticals,2013-05,2013-05-07,2020-09-03,2024-10-25T17:03:50.848735
NCT02369731,Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",PTC Therapeutics,2015-04-30,2015-02-24,2024-10-09,2024-10-25T17:03:50.848735
NCT02018731,L-citrulline and Metformin in Becker's Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker's Muscular Dystrophy (BMD),"University Hospital, Basel, Switzerland",2013-06,2013-12-23,2016-05-16,2024-10-25T17:03:50.848735
NCT06244082,Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping,RECRUITING,INTERVENTIONAL,PHASE2,"DMD, Duchenne Muscular Dystrophy, Duchenne, Exon 44","Avidity Biosciences, Inc.",2024-01-22,2024-02-06,2024-09-23,2024-10-25T17:03:50.848735
NCT03703882,Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",Catabasis Pharmaceuticals,2018-10-02,2018-10-12,2022-06-21,2024-10-25T17:03:50.848735
NCT00981266,Spectra Breast Implant Study,WITHDRAWN,INTERVENTIONAL,PHASE3,"Augmentation, Augmentation Revision, General Breast Enlargement, Post-lactational Involution, Asymmetry","Mentor Worldwide, LLC",2013-06,2009-09-22,2013-03-01,2024-10-25T17:03:50.848735
NCT02614820,"The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD",UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy (DMD),General Hospital of Chinese Armed Police Forces,2015-11,2015-11-25,2015-11-25,2024-10-25T17:03:50.848735
NCT05281120,Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Osteoporosis, Duchenne Muscular Dystrophy",Istituto Auxologico Italiano,2006-11,2022-03-16,2022-03-16,2024-10-25T17:03:50.848735
NCT02994030,Biomarker for Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Increased Lordosis/Scoliosis, Hyporeflexia, Duchenne Muscular Dystrophy, Red-Green Color Blindness, Lordosis, Scoliosis, Muscular Atrophy, Muscular Weakness",CENTOGENE GmbH Rostock,2018-08-20,2016-12-15,2022-03-24,2024-10-25T17:03:50.848735
NCT05575648,Dual Task in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2022-09-06,2022-10-12,2024-02-28,2024-10-25T17:03:50.848735
NCT03992430,A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-07-13,2019-06-20,2024-04-15,2024-10-25T17:03:50.848735
NCT05639257,Treatment of Myotonia - Lamotrigine Versus Namuscla,RECRUITING,INTERVENTIONAL,NA,Non-Dystrophic Myotonia,"Grete Andersen, MD",2022-12-05,2022-12-06,2022-12-06,2024-10-25T17:03:50.848735
NCT02819557,Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2016-06-09,2016-06-30,2020-08-28,2024-10-25T17:03:50.848735
NCT04129294,Exploratory Study of NS-089/NCNP-02 in DMD,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"National Center of Neurology and Psychiatry, Japan",2019-12-02,2019-10-16,2022-09-29,2024-10-25T17:03:50.848735
NCT02710591,Rimeporide in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",EspeRare Foundation,2016-03,2016-03-17,2019-07-18,2024-10-25T17:03:50.848735
NCT02295748,"An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort",COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,PTC Therapeutics,2014-12,2014-11-20,2017-12-08,2024-10-25T17:03:50.848735
NCT03319030,Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Ann & Robert H Lurie Children's Hospital of Chicago,2017-09-01,2017-10-24,2019-02-04,2024-10-25T17:03:50.848735
NCT04687020,Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-06-10,2020-12-29,2022-10-19,2024-10-25T17:03:50.848735
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-10-25T17:03:50.848735
NCT02310763,"A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Pfizer,2014-11-24,2014-12-08,2020-12-07,2024-10-25T17:03:50.848735
NCT05933057,"Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Italfarmaco,2024-02-19,2023-07-06,2024-09-19,2024-10-25T17:03:50.848735
NCT06594094,"An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)",NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophin (DMD),"HuidaGene Therapeutics Co., Ltd.",2024-10-30,2024-09-19,2024-10-01,2024-10-25T17:03:50.848735
NCT04906460,Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2021-09-28,2021-05-28,2024-02-28,2024-10-25T17:03:50.848735
NCT02434627,Sodium Nitrate for Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2015-06,2015-05-05,2020-01-13,2024-10-25T17:03:50.848735
NCT02484560,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,UNKNOWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,University of Gaziantep,2015-06,2015-06-29,2015-07-01,2024-10-25T17:03:50.848735
NCT04139460,CRT-P or CRT-D in Dilated Cardiomyopathy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Cardiomyopathy, Dilated, 3B",University Hospital Olomouc,2020-06,2019-10-25,2020-03-25,2024-10-25T17:03:50.848735
NCT02078076,IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère,COMPLETED,INTERVENTIONAL,NA,Duchenne or Severe Becker Myopathy,"Institut National de la Santé Et de la Recherche Médicale, France",2013-06,2014-03-05,2016-02-24,2024-10-25T17:03:50.848735
NCT05305976,Telerehabilitation in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Karadeniz Technical University,2021-01-11,2022-03-31,2022-03-31,2024-10-25T17:03:50.848735
NCT02418338,2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,"University Hospital, Montpellier",2014-01,2015-04-16,2019-06-07,2024-10-25T17:03:50.848735
NCT01772043,Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2012-09,2013-01-21,2015-07-28,2024-10-25T17:03:50.848735
NCT02037243,Disgust and Shame Based Safe Water and Handwashing Promotion,COMPLETED,INTERVENTIONAL,PHASE1,"Develop a New Group Version of the Becker-DeGroot-Marsckek (BDM) Auction to Measure Willingness to Pay of Compound Members for Shared Hardware., Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure., Identify New Methods for Measuring Hand Washing and Water Treatment Behaviour., Compare the Effectiveness of the Disgust and Shame Based Interventions With Standard Public Health Interventions.","International Centre for Diarrhoeal Disease Research, Bangladesh",2011-08,2014-01-15,2015-06-12,2024-10-25T17:03:50.848735
NCT06109103,Telerehabilitation-based Motor Imagery Training in Children With Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2023-12-15,2023-10-31,2023-10-31,2024-10-25T17:03:50.848735
NCT06378203,Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI],RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophies, Limb Girdle Muscular Dystrophy, Facio-Scapulo-Humeral Dystrophy, Becker Muscular Dystrophy",IRCCS Eugenio Medea,2023-12-15,2024-04-22,2024-04-22,2024-10-25T17:03:50.848735
NCT05291091,Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON),RECRUITING,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2022-07-06,2022-03-22,2024-09-19,2024-10-25T17:03:50.848735
NCT03689660,"Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback",UNKNOWN,INTERVENTIONAL,NA,"Neuromuscular Disease, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Virtual Reality, Biofeedback",Merve Kurt,2019-02-01,2018-09-28,2022-06-22,2024-10-25T17:03:50.848735
NCT00759876,Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2008-08-13,2008-09-25,2020-10-29,2024-10-25T17:03:50.848735
NCT03067831,Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Stem Cells Arabia,2015-09,2017-03-01,2020-03-17,2024-10-25T17:03:50.848735
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-10-25T17:03:50.848735
NCT03648827,A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2018-12-21,2018-08-27,2022-04-05,2024-10-25T17:03:50.848735
NCT05257473,Defining Endpoints in Becker Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Becker Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy in Children, Muscular Dystrophy, Becker",Virginia Commonwealth University,2022-04-13,2022-02-25,2024-10-04,2024-10-25T17:03:50.848735
NCT03179631,Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2017-07-06,2017-06-07,2024-01-18,2024-10-25T17:03:50.848735
NCT05540860,A Study of EDG-5506 in Children with Duchenne Muscular Dystrophy (LYNX),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2022-10-24,2022-09-15,2024-09-19,2024-10-25T17:03:50.848735
NCT06224660,Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,PHASE1,DMD-Associated Dilated Cardiomyopathy,Sardocor Corp.,2024-03,2024-01-25,2024-01-25,2024-10-25T17:03:50.848735
NCT04428476,Open-label Extension of the HOPE-2 Trial,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Capricor Inc.,2020-07-20,2020-06-11,2024-07-24,2024-10-25T17:03:50.848735
NCT01009294,Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD),TERMINATED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",PTC Therapeutics,2010-01-13,2009-11-06,2020-07-29,2024-10-25T17:03:50.848735
NCT05429372,Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Pfizer,2022-08-08,2022-06-23,2024-04-04,2024-10-25T17:03:50.848735
NCT04254172,A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy,TERMINATED,OBSERVATIONAL,,Duchenne Muscular Dystrophy (DMD),Pfizer,2020-02-19,2020-02-05,2021-10-15,2024-10-25T17:03:50.848735
NCT01753804,A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.,TERMINATED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2012-09-01,2012-12-20,2017-12-08,2024-10-25T17:03:50.848735
NCT03907072,Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2019-09-04,2019-04-08,2021-05-20,2024-10-25T17:03:50.848735
NCT05464446,Examination of Lower Urinary System Symptoms With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Lower Urinary Tract Symptoms, Muscle Weakness, Posture Disorders in Children, Lumbar Lordosis, Pelvic Floor Muscle Weakness, Quality of Life",Lokman Hekim Üniversitesi,2021-10-01,2022-07-19,2022-07-19,2024-10-25T17:03:50.848735
NCT02740972,Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2016-12,2016-04-15,2021-12-07,2024-10-25T17:03:50.848735
NCT03879304,Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne and Becker Types",University of Malaga,2021-03-15,2019-03-18,2024-05-13,2024-10-25T17:03:50.848735
NCT04972604,CureDuchenne Link®: A Resource for Research,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",CureDuchenne,2021-07-09,2021-07-22,2024-08-20,2024-10-25T17:03:50.848735
NCT00033189,An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2001-09,2002-04-09,2010-11-16,2024-10-25T17:03:50.848735
NCT03406780,A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic, Muscular Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",Capricor Inc.,2018-03-04,2018-01-23,2020-06-05,2024-10-25T17:03:50.848735
NCT03373968,Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study,ENROLLING_BY_INVITATION,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,Italfarmaco,2017-10-24,2017-12-14,2023-11-07,2024-10-25T17:03:50.848735
NCT01539772,Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping,UNKNOWN,OBSERVATIONAL,,Becker Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2012-04,2012-02-28,2018-06-15,2024-10-25T17:03:50.848735
NCT05688072,Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne Type",Cairo University,2023-01-15,2023-01-18,2023-04-18,2024-10-25T17:03:50.848735
NCT01183767,Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,"Charite University, Berlin, Germany",2010-12-30,2010-08-18,2021-07-29,2024-10-25T17:03:50.848735
NCT01834040,Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne Muscular Dystrophy","Chaitanya Hospital, Pune",2014-09,2013-04-17,2014-09-17,2024-10-25T17:03:50.848735
NCT04632940,Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,FibroGen,2021-03-03,2020-11-17,2024-08-26,2024-10-25T17:03:50.848735
NCT01610440,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Shenzhen Beike Bio-Technology Co., Ltd.",2011-10,2012-06-04,2012-11-30,2024-10-25T17:03:50.848735
NCT00243789,Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2005-09,2005-10-25,2011-10-27,2024-10-25T17:03:50.848735
NCT04956289,"Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-07-01,2021-07-09,2024-08-20,2024-10-25T17:03:50.848735
NCT02109692,Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies,UNKNOWN,INTERVENTIONAL,NA,"Muscular Dystrophies, Becker Muscular Dystrophy, Duchenne Muscular Dystrophy","University Hospital, Montpellier",2014-05-19,2014-04-10,2018-05-15,2024-10-25T17:03:50.848735
NCT03236662,(-)- Epicatechin Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Craig McDonald, MD",2016-11,2017-08-02,2021-11-24,2024-10-25T17:03:50.848735
NCT04782440,The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Marmara University,2021-04,2021-03-04,2021-03-04,2024-10-25T17:03:50.848735
NCT01462292,A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Muscular Dystrophies,GlaxoSmithKline,2011-10-26,2011-10-31,2017-10-16,2024-10-25T17:03:50.848735
NCT04353167,Examination of the Relationship Between Foot - Body Posture and Balance and Gait in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Foot Posture, Balance, Gait Disorders, Neurologic, Body Posture",Hacettepe University,2020-03-15,2020-04-20,2022-07-27,2024-10-25T17:03:50.848735
NCT06606340,"A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice",ENROLLING_BY_INVITATION,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2019-01-07,2024-09-23,2024-09-23,2024-10-25T17:03:50.848735
NCT02636686,Extension Study of Drisapersen in DMD Subjects,NO_LONGER_AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,,2015-12-22,2018-01-24,2024-10-25T17:03:50.848735
NCT02315339,European Home Mechanical Ventilation Registry,TERMINATED,OBSERVATIONAL,,"Pulmonary Disease, Chronic Obstructive, Amyotrophic Lateral Sclerosis, Spinal Cord Injury, Muscular Dystrophies, Obesity Hypoventilation Syndrome, Kyphoscoliosis, Congenital Central Hypoventilation Syndrome, Duchenne Muscular Dystrophy, Myopathies, Myotonic Dystrophy",ResMed,2014-08,2014-12-11,2020-04-09,2024-10-25T17:03:50.848735
NCT03039686,"Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,Hoffmann-La Roche,2017-07-06,2017-02-01,2020-12-21,2024-10-25T17:03:50.848735
NCT05564962,Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD),COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Gait Disorders in Children",Hacettepe University,2021-01-19,2022-10-04,2022-10-04,2024-10-25T17:03:50.848735
NCT03936894,Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Children's National Research Institute,2019-05-01,2019-05-03,2023-09-21,2024-10-25T17:03:50.848735
NCT05753462,"Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Sqy Therapeutics,2023-04-26,2023-03-03,2024-04-01,2024-10-25T17:03:50.848735
NCT02858362,Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Summit Therapeutics,2016-06,2016-08-08,2020-01-02,2024-10-25T17:03:50.848735
NCT02470962,Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne / Becker Muscular Dystrophy,"University Children's Hospital, Zurich",2015-05,2015-06-12,2019-07-12,2024-10-25T17:03:50.848735
NCT05185622,A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2022-03-21,2022-01-11,2024-10-16,2024-10-25T17:03:50.848735
NCT03354039,Tamoxifen in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"University Hospital, Basel, Switzerland",2018-06-12,2017-11-27,2022-12-20,2024-10-25T17:03:50.848735
NCT05135663,Extension Study of NS-089/NCNP-02 in DMD,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),"Nippon Shinyaku Co., Ltd.",2021-06-23,2021-11-26,2023-03-03,2024-10-25T17:03:50.848735
NCT01396239,Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2011-07,2011-07-18,2020-03-30,2024-10-25T17:03:50.848735
NCT02036463,A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy,WITHDRAWN,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),Ann & Robert H Lurie Children's Hospital of Chicago,2014-11,2014-01-15,2015-02-18,2024-10-25T17:03:50.848735
NCT04821063,Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval,COMPLETED,INTERVENTIONAL,PHASE1,"Duchenne and Becker Muscular Dystrophy, Polycytemia Vera",Italfarmaco,2021-04-13,2021-03-29,2024-01-11,2024-10-25T17:03:50.848735
NCT06328725,Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,ENCell,2024-03,2024-03-25,2024-03-25,2024-10-25T17:03:50.848735
NCT02194725,"Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy",COMPLETED,OBSERVATIONAL,,Stress,National Human Genome Research Institute (NHGRI),2014-07-06,2014-07-18,2018-04-05,2024-10-25T17:03:50.848735
NCT06174025,Validity and Reliability of the 6 Minute Pegboard Ring Test,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Çağtay Maden,2023-06-30,2023-12-18,2024-01-12,2024-10-25T17:03:50.848735
NCT03507530,Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,"Neuromuscular Diseases, Duchenne Muscular Dystrophy, Dystrophy, Dystrophy, Muscular",Canan İpek,2018-04,2018-04-25,2018-04-27,2024-10-25T17:03:50.848735
NCT02147639,Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3",Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2013-10,2014-05-28,2020-01-14,2024-10-25T17:03:50.848735
NCT06013839,TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy,RECRUITING,INTERVENTIONAL,PHASE2,DMD-Associated Dilated Cardiomyopathy,Constant Therapeutics LLC,2023-08-31,2023-08-28,2024-01-23,2024-10-25T17:03:50.848735
NCT06450639,An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Hoffmann-La Roche,2024-10-31,2024-06-10,2024-10-23,2024-10-25T17:03:50.848735
NCT06138639,A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE),RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Solid Biosciences Inc.,2024-05-06,2023-11-18,2024-10-15,2024-10-25T17:03:50.848735
NCT01826422,Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne","Coordinación de Investigación en Salud, Mexico",2013-03,2013-04-08,2018-03-09,2024-10-25T17:03:50.848735
NCT01834066,Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne Muscular Dystrophy,","Chaitanya Hospital, Pune",2014-09,2013-04-17,2014-09-17,2024-10-25T17:03:50.848735
NCT04336826,A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to <2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),COMPLETED,INTERVENTIONAL,PHASE2,Nonsene Mutation Duchenne Muscular Dystrophy,PTC Therapeutics,2021-12-29,2020-04-07,2024-04-01,2024-10-25T17:03:50.848735
NCT04371666,Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,FibroGen,2020-08-10,2020-05-01,2024-03-12,2024-10-25T17:03:50.848735
NCT03979157,Non-invasive Molecular Imaging of Muscle Structure (MSOT_muscles),COMPLETED,INTERVENTIONAL,NA,Muscular Diseases,University of Erlangen-Nürnberg Medical School,2019-10-14,2019-06-07,2020-07-07,2024-10-25T17:03:50.848735
NCT02704325,Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2,WITHDRAWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Kevin Flanigan,2016-04,2016-03-10,2018-02-06,2024-10-25T17:03:50.848735
NCT02752048,A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2016-05,2016-04-26,2020-04-20,2024-10-25T17:03:50.848735
NCT05280730,Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Virginia Commonwealth University,2022-02-02,2022-03-15,2024-04-16,2024-10-25T17:03:50.848735
NCT00758225,"Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2008-09,2008-09-25,2011-06-01,2024-10-25T17:03:50.848735
NCT00428935,Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Nationwide Children's Hospital,2006-03,2007-01-30,2013-02-05,2024-10-25T17:03:50.848735
NCT02165358,Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I,COMPLETED,OBSERVATIONAL,,"Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2I","Rigshospitalet, Denmark",2014-06,2014-06-17,2016-11-11,2024-10-25T17:03:50.848735
NCT01239758,Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",2010-10,2010-11-11,2013-02-01,2024-10-25T17:03:50.848735
NCT03238235,Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,Italfarmaco,2017-12-12,2017-08-03,2022-01-26,2024-10-25T17:03:50.848735
NCT03558958,Safety and Efficacy of P-188 NF in DMD Patients,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Phrixus Pharmaceuticals, Inc.",2018-08-08,2018-06-15,2023-01-11,2024-10-25T17:03:50.848735
NCT05019625,Biomarker Development for Muscular Dystrophies,RECRUITING,OBSERVATIONAL,,"Myotonic Dystrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy",Massachusetts General Hospital,2015-02-20,2021-08-25,2023-10-06,2024-10-25T17:03:50.848735
NCT01478022,"To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20",COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),"Parent Project, Italy",2011-10,2011-11-23,2018-08-31,2024-10-25T17:03:50.848735
NCT00799266,An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids,COMPLETED,INTERVENTIONAL,PHASE3,Osteoporosis,Novartis Pharmaceuticals,2008-12-04,2008-11-27,2020-09-02,2024-10-25T17:03:50.848735
NCT02081625,Exploratory Study of NS-065/NCNP-01 in DMD,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"National Center of Neurology and Psychiatry, Japan",2013-06,2014-03-07,2020-02-26,2024-10-25T17:03:50.848735
NCT05670730,Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2","Duchenne Muscular Dystrophy, Exon 44","Avidity Biosciences, Inc.",2022-11-09,2023-01-04,2024-09-23,2024-10-25T17:03:50.848735
NCT05126758,A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,PHASE3,"Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic, Muscular Diseases, Neuromuscular Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn, Nervous System Diseases",Capricor Inc.,2022-06-22,2021-11-19,2024-07-23,2024-10-25T17:03:50.848735
NCT06124196,Wearable Technology to Evaluate Hyperglycemia and HRV in DMD,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Vanderbilt University Medical Center,2024-03-20,2023-11-09,2024-04-01,2024-10-25T17:03:50.848735
NCT06540365,Applying the Pathways and Resources for Engagement and Participation Protocol Among People With Muscles Dystrophies,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",University of Haifa,2024-08,2024-08-06,2024-08-06,2024-10-25T17:03:50.848735
NCT04004065,"Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment",ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2019-06-26,2019-07-01,2024-10-03,2024-10-25T17:03:50.848735
NCT01978366,Open Label Extension Study of HT-100 in Patients With DMD,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Processa Pharmaceuticals,2013-10,2013-11-07,2020-09-03,2024-10-25T17:03:50.848735
NCT01506518,Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne","University of North Carolina, Chapel Hill",2012-01,2012-01-10,2021-08-02,2024-10-25T17:03:50.848735
NCT06290713,Vasodilator and Exercise Study for DMD (VASO-REx),RECRUITING,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in Children, Vasodilation, Exercise, DMD",University of Florida,2024-06-05,2024-03-04,2024-06-25,2024-10-25T17:03:50.848735
NCT04173234,Aerobic Exercise in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2019-04-11,2019-11-21,2021-09-30,2024-10-25T17:03:50.848735
NCT01385917,Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2011-10,2011-06-30,2016-04-12,2024-10-25T17:03:50.848735
NCT01648634,Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Duchenne Muscular Dystrophy, Cardiomyopathy, Heart Failure",Assistance Publique - Hôpitaux de Paris,2012-02-13,2012-07-24,2021-09-28,2024-10-25T17:03:50.848735
NCT00893334,Evaluation of Limb-Girdle Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency), Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency), Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)",Cooperative International Neuromuscular Research Group,2009-04,2009-05-06,2014-03-07,2024-10-25T17:03:50.848735
NCT04386304,Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Epirium Bio Inc.,2020-07-13,2020-05-13,2022-03-23,2024-10-25T17:03:50.848735
NCT03513367,The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"University Hospital, Toulouse",2018-09-19,2018-05-01,2019-04-18,2024-10-25T17:03:50.848735
NCT01540604,"CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers",COMPLETED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",RSPR Pharma AB,,2012-02-29,2012-10-02,2024-10-25T17:03:50.848735
NCT02329769,"Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2014-12,2015-01-01,2017-12-08,2024-10-25T17:03:50.848735
NCT00004646,"Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,National Center for Research Resources (NCRR),1995-04,2000-02-25,2005-06-24,2024-10-25T17:03:50.848735
NCT06337669,Characterization of DupEx2 Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",IRCCS San Raffaele,2022-01-31,2024-03-29,2024-03-29,2024-10-25T17:03:50.848735
NCT00110669,High-dose Prednisone in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2004-01,2005-05-13,2011-10-27,2024-10-25T17:03:50.848735
NCT04768062,Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-04-13,2021-02-24,2024-02-14,2024-10-25T17:03:50.848735
NCT02500381,Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2016-09-28,2015-07-16,2024-10-01,2024-10-25T17:03:50.848735
NCT05436210,Postural and Anthropometric Properties of Foot and Ankle of Patients With DMD,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Ambulation Difficulty, Posture Disorders in Children, Ambulation Disorder, Neurologic",Hacettepe University,2022-06-23,2022-06-29,2023-01-04,2024-10-25T17:03:50.848735
NCT02235844,Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne's Muscular Dystrophy,"Allergy and Asthma Consultants, Wichita, Kansas",2014-09,2014-09-10,2019-09-16,2024-10-25T17:03:50.848735
NCT01081080,Cardiac Magnetic Resonance in Children With Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy",Cooperative International Neuromuscular Research Group,2010-04,2010-03-05,2013-01-11,2024-10-25T17:03:50.848735
NCT02972580,Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",Nationwide Children's Hospital,2016-06,2016-11-23,2024-08-27,2024-10-25T17:03:50.848735
NCT06066580,Open-Label Extension of EDG-5506 in Participants with Becker Muscular Dystrophy,ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2023-11-02,2023-10-04,2024-10-24,2024-10-25T17:03:50.848735
NCT03760029,A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Pfizer,2019-07-24,2018-11-30,2024-09-19,2024-10-25T17:03:50.848735
NCT00390104,Molecular Analysis of Patients With Neuromuscular Disease,RECRUITING,OBSERVATIONAL,,"Neuromuscular; Disorder, Hereditary, Duchenne/Becker Muscular Dystrophy, Limb-girdle Muscular Dystrophy",Boston Children's Hospital,2002-01,2006-10-19,2023-04-24,2024-10-25T17:03:50.848735
NCT01954940,Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Children's Hospital of Eastern Ontario,2013-03,2013-10-07,2018-08-31,2024-10-25T17:03:50.848735
NCT06053814,NS-050/NCNP-03 in Boys With DMD (Meteor50),NOT_YET_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2024-07,2023-09-26,2024-02-15,2024-10-25T17:03:50.848735
NCT06186310,Effectiveness of Aquatic Therapy in Children With Duchenne and Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne or Becker Muscular Dystrophy,Gaziosmanpasa Research and Education Hospital,2023-11-05,2024-01-02,2024-03-12,2024-10-25T17:03:50.848735
NCT06539169,FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases,RECRUITING,OBSERVATIONAL,,"Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis, Amyotrophic Lateral Sclerosis, Creutzfeld-Jakob Disease, Cystic Fibrosis, Duchenne Muscular Dystrophy, Early-Onset Alzheimer Disease, Ehlers-Danlos Syndrome, Huntington Disease, Gaucher Disease, GM1 Gangliosidosis, Myasthenia Gravis, Pompe Disease, Sickle Cell Disease, Transthyretin Amyloid Cardiomyopathy, Rare Diseases",xCures,2024-06-10,2024-08-06,2024-08-14,2024-10-25T17:03:50.848735
NCT02196467,Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,CHU de Quebec-Universite Laval,2014-05,2014-07-22,2021-01-29,2024-10-25T17:03:50.848735
NCT01098708,This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Washington University School of Medicine,2010-03,2010-04-05,2017-01-18,2024-10-25T17:03:50.848735
NCT04587908,A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2020-11-01,2020-10-14,2024-08-14,2024-10-25T17:03:50.848735
NCT06241950,A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74),ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2024-01-29,2024-02-05,2024-08-13,2024-10-25T17:03:50.848735
NCT00159250,Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Imperial College London,2007-10-26,2005-09-12,2019-12-05,2024-10-25T17:03:50.848735
NCT04120168,Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Pompe Disease (Late-onset)","Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition",2019-04-01,2019-10-09,2022-10-24,2024-10-25T17:03:50.848735
NCT01580501,PDE Inhibitors in DMD Study (Acute Dosing Study),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Cedars-Sinai Medical Center,2012-03,2012-04-19,2014-01-28,2024-10-25T17:03:50.848735
NCT02907619,An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Pfizer,2016-10-13,2016-09-20,2020-11-23,2024-10-25T17:03:50.848735
NCT06574919,Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital,RECRUITING,OBSERVATIONAL,,Inherited Non-Duchenne Myopathies,Sohag University,2024-08-01,2024-08-28,2024-08-28,2024-10-25T17:03:50.848735
NCT02814019,A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy (DMD),Santhera Pharmaceuticals,2016-09,2016-06-27,2021-12-03,2024-10-25T17:03:50.848735
NCT04668716,Brain Involvement in Dystrophinopathies Part 2,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",Great Ormond Street Hospital for Children NHS Foundation Trust,2021-10-11,2020-12-16,2024-07-22,2024-10-25T17:03:50.848735
NCT02241434,Stem Cell Therapy in Duchenne Muscular Dystrophy,WITHDRAWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Neurogen Brain and Spine Institute,2009-01,2014-09-16,2018-10-25,2024-10-25T17:03:50.848735
NCT06392724,A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy (DMD),Peking Union Medical College Hospital,2024-07,2024-04-30,2024-07-08,2024-10-25T17:03:50.848735
NCT04433234,"Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy",ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Daiichi Sankyo Co., Ltd.",2020-06-30,2020-06-16,2024-08-29,2024-10-25T17:03:50.848735
NCT04607824,Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Sao Paulo,2014-03,2020-10-29,2020-10-29,2024-10-25T17:03:50.848735
NCT03127241,User-centred Assistive System for Arm Functions in Neuromuscular Subjects,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Becker, Muscular Dystrophy, Limb-Girdle Type 2",Politecnico di Milano,2017-06-16,2017-04-25,2019-12-10,2024-10-25T17:03:50.848735
NCT02167217,Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Washington University School of Medicine,2014-04-17,2014-06-19,2018-12-21,2024-10-25T17:03:50.848735
NCT03789734,Safety Study of BLS-M22 in Healthy Volunteers,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",BioLeaders Corporation,2019-06-04,2018-12-31,2021-04-22,2024-10-25T17:03:50.848735
NCT03777319,Spironolactone Versus Prednisolone in DMD,TERMINATED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",Kevin Flanigan,2018-12-05,2018-12-17,2023-10-23,2024-10-25T17:03:50.848735
NCT06295718,Tele-assessment of Functional Performance and Quality of Life in Patients With Duchenne Muscular Dystrophy: Validity and Reliability Study,ENROLLING_BY_INVITATION,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Sahra Şirvan,2023-07-01,2024-03-06,2024-03-06,2024-10-25T17:03:50.848735
NCT04583917,Brain Involvement in Dystrophinopathies Part 1,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",Great Ormond Street Hospital for Children NHS Foundation Trust,2021-03-30,2020-10-12,2024-07-22,2024-10-25T17:03:50.848735
NCT05982119,Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study,RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy 1, Charcot-Marie-Tooth, Centronuclear Myopathy, Congenital Muscular Dystrophy",Laurent Servais,2020-07-10,2023-08-08,2024-05-30,2024-10-25T17:03:50.848735
NCT01254019,A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Muscular Dystrophies,GlaxoSmithKline,2010-12-02,2010-12-06,2019-01-28,2024-10-25T17:03:50.848735
NCT02592941,"Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy",APPROVED_FOR_MARKETING,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,PTC Therapeutics,,2015-10-30,2018-02-28,2024-10-25T17:03:50.848735
NCT03863119,Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy,AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,,2019-03-05,2023-11-09,2024-10-25T17:03:50.848735
NCT06270719,An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2024-02-07,2024-02-21,2024-09-03,2024-10-25T17:03:50.848735
NCT03917719,An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Catabasis Pharmaceuticals,2019-03-14,2019-04-17,2020-11-23,2024-10-25T17:03:50.848735
NCT01910649,"A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration",TERMINATED,INTERVENTIONAL,PHASE2,Muscular Dystrophies,BioMarin Pharmaceutical,2008-03,2013-07-29,2016-11-06,2024-10-25T17:03:50.848735
NCT02376816,Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Jerry R. Mendell,2015-03,2015-03-03,2017-11-24,2024-10-25T17:03:50.848735
NCT01890616,Constipation and Gut Transit in DMD Patients,COMPLETED,OBSERVATIONAL,,"Constipation, DMD","Children's Hospital Medical Center, Cincinnati",2013-05-01,2013-07-02,2020-09-16,2024-10-25T17:03:50.848735
NCT03769116,"A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2018-12-05,2018-12-07,2023-10-25,2024-10-25T17:03:50.848735
NCT01182324,"The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,National Human Genome Research Institute (NHGRI),2010-07-30,2010-08-16,2018-04-05,2024-10-25T17:03:50.848735
NCT02161835,Relations Between Myotonia and Fitness,COMPLETED,INTERVENTIONAL,NA,Congenital Myotonia,"Grete Andersen, MD",2014-04,2014-06-12,2015-05-14,2024-10-25T17:03:50.848735
NCT05601986,Motor Imagery on Children With DMD on Gait and Balance Functions,RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Gülsena Utku,2022-12-16,2022-11-01,2024-02-29,2024-10-25T17:03:50.848735
NCT02606136,"Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,FibroGen,2016-01-04,2015-11-17,2024-08-27,2024-10-25T17:03:50.848735
NCT05558813,Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP),NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Assistance Publique - Hôpitaux de Paris,2024-11,2022-09-28,2023-10-30,2024-10-25T17:03:50.848735
NCT03786913,Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases,COMPLETED,OBSERVATIONAL,,"Inflammatory Myopathy, Duchenne Muscular Dystrophy",Benha University,2016-03-08,2018-12-26,2019-02-08,2024-10-25T17:03:50.848735
NCT00308113,CoQ10 and Prednisone in Non-Ambulatory DMD,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2007-04,2006-03-29,2013-11-08,2024-10-25T17:03:50.848735
NCT03534349,Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Performance, Flexibility",Hacettepe University,2017-01,2018-05-23,2018-05-24,2024-10-25T17:03:50.848735
NCT03541070,The Effect of Kinesiology Taping on Balance in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Balance, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-30,2018-05-30,2024-10-25T17:03:50.848735
NCT01957059,A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2013-06,2013-10-08,2017-12-08,2024-10-25T17:03:50.848735
NCT03340675,Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated",Cumberland Pharmaceuticals,2020-10-19,2017-11-13,2024-10-23,2024-10-25T17:03:50.848735
NCT04054375,Weekly Steroids in Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Limb-girdle Muscular Dystrophy, Becker Muscular Dystrophy",Northwestern University,2019-07-01,2019-08-13,2023-09-21,2024-10-25T17:03:50.848735
NCT02090959,An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy,TERMINATED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2014-03-20,2014-03-19,2020-08-11,2024-10-25T17:03:50.848735
NCT03947112,Physical Activity Level of Norwegian Boys With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Haukeland University Hospital,2020-08-20,2019-05-13,2021-12-29,2024-10-25T17:03:50.848735
NCT01803412,"A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects",TERMINATED,INTERVENTIONAL,PHASE3,Muscular Dystrophies,BioMarin Pharmaceutical,2013-05-01,2013-03-04,2018-06-14,2024-10-25T17:03:50.848735
NCT03218995,Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2017-08-16,2017-07-17,2021-12-09,2024-10-25T17:03:50.848735
NCT05330195,Bicycle Ergometer Training in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Hacettepe University,2022-04-18,2022-04-15,2023-10-11,2024-10-25T17:03:50.848735
NCT01982695,Cardiomyopathy in DMD: Lisinopril vs. Losartan,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy (DMD), Cardiomyopathy",Nationwide Children's Hospital,2009-03,2013-11-13,2017-03-21,2024-10-25T17:03:50.848735
NCT01451281,"Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy",COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Muscular Disease",National Institute of Neurological Disorders and Stroke (NINDS),2011-09-15,2011-10-13,2019-05-22,2024-10-25T17:03:50.848735
NCT03655223,Early Check: Expanded Screening in Newborns,ENROLLING_BY_INVITATION,OBSERVATIONAL,,"Spinal Muscular Atrophy, Fragile X Syndrome, Fragile X - Premutation, Duchenne Muscular Dystrophy, Hyperinsulinemic Hypoglycemia, Familial 1, Diabetes Mellitus, Adrenoleukodystrophy, Neonatal, Medium-chain Acyl-CoA Dehydrogenase Deficiency, Very Long Chain Acyl Coa Dehydrogenase Deficiency, Beta-ketothiolase Deficiency, Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency, Primary Hyperoxaluria Type 1, Congenital Bile Acid Synthesis Defect Type 2, Pyridoxine-Dependent Epilepsy, Hereditary Fructose Intolerance, Hypophosphatasia, Hyperargininemia, Mucopolysaccharidosis Type 6, Argininosuccinic Aciduria, Citrullinemia, Type I, Wilson Disease, Maple Syrup Urine Disease, Type 1A, Maple Syrup Urine Disease, Type 1B, Biotinidase Deficiency, Neonatal Severe Primary Hyperparathyroidism, Intrinsic Factor Deficiency, Usher Syndrome Type 1D/F Digenic (Diagnosis), Cystic Fibrosis, Stickler Syndrome Type 2, Stickler Syndrome Type 1, Alport Syndrome, Autosomal Recessive, Alport Syndrome, X-Linked, Carbamoyl Phosphate Synthetase I Deficiency Disease, Carnitine Palmitoyl Transferase 1A Deficiency, Carnitine Palmitoyltransferase II Deficiency, Cystinosis, Chronic Granulomatous Disease, Cerebrotendinous Xanthomatoses, Maple Syrup Urine Disease, Type 2, Severe Combined Immunodeficiency Due to DCLRE1C Deficiency, Thyroid Dyshormonogenesis 6, Thyroid Dyshormonogenesis 5, Supravalvar Aortic Stenosis, Factor X Deficiency, Hemophilia A, Hemophilia B, Tyrosinemia, Type I, Fructose 1,6 Bisphosphatase Deficiency, Glycogen Storage Disease Type I, G6PD Deficiency, Glycogen Storage Disease II, Galactokinase Deficiency, Mucopolysaccharidosis Type IV A, Galactosemias, Guanidinoacetate Methyltransferase Deficiency, Agat Deficiency, Glutaryl-CoA Dehydrogenase Deficiency, Gtp Cyclohydrolase I Deficiency, Hyperinsulinism-Hyperammonemia Syndrome, Primary Hyperoxaluria Type 2, 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, Mitochondrial Trifunctional Protein Deficiency, Sickle Cell Disease, Beta-Thalassemia, Holocarboxylase Synthetase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, Primary Hyperoxaluria Type 3, Hermansky-Pudlak Syndrome 1, Hermansky-Pudlak Syndrome 4, Apparent Mineralocorticoid Excess, HSDB, CBAS1, Mucopolysaccharidosis Type 2, Mucopolysaccharidosis Type 1, Severe Combined Immunodeficiency, X Linked, Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency, Diabetes Mellitus, Permanent Neonatal, Isovaleric Acidemia, Severe Combined Immunodeficiency T-Cell Negative B-Cell Positive Due to Janus Kinase-3 Deficiency (Disorder), Jervell and Lange-Nielsen Syndrome 2, Hyperinsulinemic Hypoglycemia, Familial, 2, Diabetes Mellitus, Permanent Neonatal, With Neurologic Features, Jervell and Lange-Nielsen Syndrome 1, Lysosomal Acid Lipase Deficiency, CblF, 3-Methylcrotonyl CoA Carboxylase 1 Deficiency, 3-Methylcrotonyl CoA Carboxylase 2 Deficiency, Waardenburg Syndrome Type 2A, Methylmalonic Aciduria cblA Type, Methylmalonic Aciduria cblB Type, Methylmalonic Aciduria and Homocystinuria Type cblC, MAHCD, Methylmalonic Aciduria Due to Methylmalonyl-CoA Mutase Deficiency, Congenital Disorder of Glycosylation Type 1B, Mthfr Deficiency, Methylcobalamin Deficiency Type Cbl G (Disorder), Methylcobalamin Deficiency Type cblE, Usher Syndrome, Type 1B, N-acetylglutamate Synthase Deficiency, Ornithine Transcarbamylase Deficiency, Phenylketonurias, Waardenburg Syndrome Type 1, Congenital Hypothyroidism, Propionic Acidemia, Usher Syndrome, Type 1F, Pancreatic Agenesis 1, Hereditary Hypophosphatemic Rickets, Glycogen Storage Disease IXB, Glycogen Storage Disease IXC, MOWS, Epilepsy, Early-Onset, Vitamin B6-Dependent, Pyridoxal Phosphate-Responsive Seizures, Pituitary Hormone Deficiency, Combined, 1, Ptsd, Dihydropteridine Reductase Deficiency, Severe Combined Immunodeficiency Due to RAG1 Deficiency, Severe Combined Immunodeficiency Due to RAG2 Deficiency, Retinoblastoma, Multiple Endocrine Neoplasia Type 2B, Pseudohypoaldosteronism, Type I, Liddle Syndrome, Biotin-Responsive Basal Ganglia Disease, SCD, DIAR1, GSD1C, Acrodermatitis Enteropathica, Thyroid Dyshormonogenesis 1, Riboflavin Transporter Deficiency, Waardenburg Syndrome, Type 2E, SRD, Congenital Lipoid Adrenal Hyperplasia Due to STAR Deficiency, Barth Syndrome, Adrenocorticotropic Hormone Deficiency, Transcobalamin II Deficiency, Thyroid Dyshormonogenesis 3, Segawa Syndrome, Autosomal Recessive, Autosomal Recessive Nonsyndromic Hearing Loss, Thyroid Dyshormonogenesis 2A, Congenital Isolated Thyroid Stimulating Hormone Deficiency, Hypothyroidism Due to TSH Receptor Mutations, Usher Syndrome Type 1C, Usher Syndrome Type 1G (Diagnosis), Von Willebrand Disease, Type 3, Combined Immunodeficiency Due to ZAP70 Deficiency, Adenine Phosphoribosyltransferase Deficiency, Metachromatic Leukodystrophy, Canavan Disease, Menkes Disease, Carbonic Anhydrase VA Deficiency, Developmental and Epileptic Encephalopathy 2, 17 Alpha-Hydroxylase Deficiency, Smith-Lemli-Opitz Syndrome, Krabbe Disease, Glutathione Synthetase Deficiency, Mucopolysaccharidosis Type 7, Rett Syndrome, Molybdenum Cofactor Deficiency, Type A, Niemann-Pick Disease, Type C1, Niemann-Pick Disease Type C2, Ornithine Aminotransferase Deficiency, 3-Phosphoglycerate Dehydrogenase Deficiency, Leber Congenital Amaurosis 2, Dravet Syndrome, Mucopolysaccharidosis Type 3 A, Ornithine Translocase Deficiency, Carnitine-acylcarnitine Translocase Deficiency, Glucose Transporter Type 1 Deficiency Syndrome, Creatine Transporter Deficiency, Niemann-Pick Disease Type A, Pitt Hopkins Syndrome, Tuberous Sclerosis 1, Tuberous Sclerosis 2, Ataxia With Isolated Vitamin E Deficiency, Angelman Syndrome, Prader-Willi Syndrome, Homocystinuria, Permanent Neonatal Diabetes Mellitus, Transient Neonatal Diabetes Mellitus, Factor VII Deficiency, Glycogen Storage Disease Type IXA1, Glycogen Storage Disease, Type IXA2, Glycogen Storage Disease IC, Glycogen Storage Disease Type IB, Central Hypoventilation Syndrome With or Without Hirschsprung Disease",RTI International,2018-10-15,2018-08-31,2024-03-27,2024-10-25T17:03:50.848735
NCT02413450,Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias,ENROLLING_BY_INVITATION,OBSERVATIONAL,,"Inherited Cardiac Arrythmias, Long QT Syndrome (LQTS), Brugada Syndrome (BrS), Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Early Repolarization Syndrome (ERS), Arrhythmogenic Cardiomyopathy (AC, ARVD/C), Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy), Normal Control Subjects",Johns Hopkins University,2013-08,2015-04-10,2024-01-08,2024-10-25T17:03:50.848735
NCT05990608,Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy (DMD),Ondokuz Mayıs University,2021-07-30,2023-08-14,2023-08-14,2024-10-25T17:03:50.848735
NCT06643923,Effects of Lumbopelvic Stabilization-based Physiotherapy and Rehabilitation Training in Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy (DMD), Lower Urinary Track Symptoms",Lokman Hekim Üniversitesi,2024-12-01,2024-10-16,2024-10-16,2024-10-25T17:03:50.848735
NCT05881408,A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2023-05-31,2023-05-31,2024-10-24,2024-10-25T17:03:50.848735
NCT02421523,Strength Training in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Florida,2015-05-30,2015-04-20,2019-03-06,2024-10-25T17:03:50.848735
NCT01335295,Safety Study of Flavocoxid in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,University of Messina,2011-03,2011-04-14,2014-02-03,2024-10-25T17:03:50.848735
NCT05313295,Physical Therapy Treatment on Children and Adolescents With Neurological Pathologies,COMPLETED,INTERVENTIONAL,NA,"Neurologic Disorder, Duchenne, Pediatric Disorder, Sensorimotor Disorder Nos",Universidad de Almeria,2018-11-01,2022-04-06,2023-05-23,2024-10-25T17:03:50.848735
NCT02354781,Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Jerry R. Mendell,2015-01,2015-02-03,2023-10-11,2024-10-25T17:03:50.848735
NCT05559710,Motor Imagery in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2022-06-20,2022-09-29,2023-12-05,2024-10-25T17:03:50.848735
NCT04708314,An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,"Rare Disease Research, LLC",2020-10-31,2021-01-13,2021-05-17,2024-10-25T17:03:50.848735
NCT04240314,AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Megan Waldrop,2020-01-15,2020-01-27,2023-02-09,2024-10-25T17:03:50.848735
NCT03589612,Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Performance, Flexibility",Hacettepe University,2018-03-08,2018-07-18,2019-09-30,2024-10-25T17:03:50.848735
NCT01000012,Compassionate Use of the Becker Expander/Breast Implant,NO_LONGER_AVAILABLE,EXPANDED_ACCESS,,Breast Reconstruction,"Mentor Worldwide, LLC",,2009-10-22,2013-10-29,2024-10-25T17:03:50.848735
NCT04337112,The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation,APPROVED_FOR_MARKETING,EXPANDED_ACCESS,,"Muscular Dystrophy, Duchenne, DMD","NS Pharma, Inc.",,2020-04-07,2020-08-18,2024-10-25T17:03:50.848735
NCT03779646,Bisoprolol in DMD Early Cardiomyopathy,UNKNOWN,INTERVENTIONAL,"PHASE2, PHASE3","Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated",Peking Union Medical College Hospital,2019-01-16,2018-12-19,2022-09-28,2024-10-25T17:03:50.848735
NCT06641895,Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy (DMD),Shanghai Jiao Tong University School of Medicine,2024-07-25,2024-10-15,2024-10-15,2024-10-25T17:03:50.848735
NCT05244395,Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Gait Disorders in Children, Gait Disorders, Neurologic",Hacettepe University,2020-02-10,2022-02-17,2022-03-07,2024-10-25T17:03:50.848735
NCT01521546,Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Subha Raman,2012-02,2012-01-30,2016-11-08,2024-10-25T17:03:50.848735
NCT02515669,"Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD",TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Muscular Dystrophy (DMD),Hoffmann-La Roche,2015-12-02,2015-08-05,2020-11-04,2024-10-25T17:03:50.848735
NCT01856868,Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Becker Muscular Dystrophy,"Craig McDonald, MD",2013-05,2013-05-17,2021-12-22,2024-10-25T17:03:50.848735
NCT01168908,Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",2010-09,2010-07-23,2019-02-26,2024-10-25T17:03:50.848735
NCT05938023,A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Percheron Therapeutics,2023-05-18,2023-07-10,2024-05-30,2024-10-25T17:03:50.848735
NCT02056808,A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Summit Therapeutics,2013-11,2014-02-06,2014-08-27,2024-10-25T17:03:50.848735
NCT02168114,Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Florida,2014-07,2014-06-20,2018-01-12,2024-10-25T17:03:50.848735
NCT03490214,Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy, Duchenne",University of Erlangen-Nürnberg Medical School,2018-06-01,2018-04-06,2019-12-09,2024-10-25T17:03:50.848735
NCT06147414,Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders,NOT_YET_RECRUITING,OBSERVATIONAL,,"Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease, Cystic Fibrosis, Fragile X Syndrome, Proximal Spinal Muscular Atrophy, Myotonic Dystrophy, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Becker, Neurofibromatosis-Noonan Syndrome, Huntington Disease, Hemophilia A, Hemophilia B, MODY2 Diabetes, X-Linked Hydrocephalus, Autosomal Recessive Polycystic Kidney Disease",Assistance Publique - Hôpitaux de Paris,2024-04,2023-11-27,2024-02-28,2024-10-25T17:03:50.848735
NCT05657938,Evaluation of Home Based Assessments on Participants With DMD,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Solid Biosciences Inc.,2022-10-13,2022-12-20,2023-08-14,2024-10-25T17:03:50.848735
NCT06565208,First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy,"Satellos Bioscience, Inc.",2024-08-21,2024-08-21,2024-09-27,2024-10-25T17:03:50.848735
NCT01207908,Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Children's Hospital Medical Center, Cincinnati",2010-11,2010-09-23,2021-01-20,2024-10-25T17:03:50.848735
NCT05016908,Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Massachusetts General Hospital,2019-11-30,2021-08-23,2023-10-12,2024-10-25T17:03:50.848735
NCT05274555,Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Extremity Problem",Dokuz Eylul University,2019-03-27,2022-03-10,2022-06-09,2024-10-25T17:03:50.848735
NCT03167255,Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2017-07-06,2017-05-25,2022-12-28,2024-10-25T17:03:50.848735
NCT01128855,"A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects",COMPLETED,INTERVENTIONAL,PHASE1,Muscular Dystrophies,GlaxoSmithKline,2010-07-12,2010-05-24,2017-07-18,2024-10-25T17:03:50.848735
NCT01491555,Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Boston Children's Hospital,2012-04,2011-12-14,2016-03-24,2024-10-25T17:03:50.848735
NCT03375255,"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)",COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2018-02-05,2017-12-18,2022-07-06,2024-10-25T17:03:50.848735
NCT03372655,Prognostic Factors Affecting Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Assiut University,2018-01-01,2017-12-14,2017-12-14,2024-10-25T17:03:50.848735
NCT01066455,Cardiac Outcome Measures in Children With Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy",Cooperative International Neuromuscular Research Group,2010-01,2010-02-10,2013-01-11,2024-10-25T17:03:50.848735
NCT02834650,Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne",Stanford University,2017-02-01,2016-07-15,2022-05-10,2024-10-25T17:03:50.848735
NCT02835079,Treatment Effect of Tamoxifen on Patients With DMD,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Hadassah Medical Organization,2016-11,2016-07-15,2022-07-25,2024-10-25T17:03:50.848735
NCT02340923,"A Device for Rapid, Painless, Bedside Muscle Evaluation of Children",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Skulpt, Inc.",2015-01,2015-01-19,2016-08-11,2024-10-25T17:03:50.848735
NCT05409079,Schulze Muscular Dystrophy Ability Clinical Study,RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophies, Spinal Muscular Atrophy, Duchenne Muscular Dystrophy, Limb Girdle Muscular Dystrophy, FSHD, Cerebral Palsy, Becker Muscular Dystrophy",AbiliTech Medical Inc.,2022-05-26,2022-06-08,2022-12-05,2024-10-25T17:03:50.848735
NCT02891434,Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Sao Paulo,2016-02,2016-09-07,2017-04-11,2024-10-25T17:03:50.848735
NCT00033813,KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2002-01,2002-04-11,2014-03-10,2024-10-25T17:03:50.848735
NCT06079736,A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PepGen Inc,2024-01-08,2023-10-12,2024-05-13,2024-10-25T17:03:50.848735
NCT04060199,Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53),COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2020-04-14,2019-08-19,2023-10-27,2024-10-25T17:03:50.848735
NCT05549999,"Cultural Adaptation, Validity, and Reliability of the Turkish Version of North Star Ambulatory Assessment",COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Ambulation Difficulty, Ambulation Disorder, Neurologic",Hacettepe University,2022-11-01,2022-09-22,2023-07-28,2024-10-25T17:03:50.848735
NCT05338099,Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD),COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,ENCell,2022-01-18,2022-04-20,2024-08-30,2024-10-25T17:03:50.848735
NCT02195999,Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",University of Florida,2013-12,2014-07-21,2019-07-08,2024-10-25T17:03:50.848735
NCT03038399,Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2017-02-02,2017-01-31,2021-05-20,2024-10-25T17:03:50.848735
NCT03532542,An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2018-08-02,2018-05-22,2024-09-19,2024-10-25T17:03:50.848735
NCT02310906,Phase I/II Study of SRP-4053 in DMD Patients,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2015-01-13,2014-12-08,2020-10-19,2024-10-25T17:03:50.848735
NCT01286870,Becker Continued Access Study,TERMINATED,INTERVENTIONAL,PHASE4,Breast Reconstruction,"Mentor Worldwide, LLC",2009-06-01,2011-01-31,2019-03-06,2024-10-25T17:03:50.848735
NCT05195775,Tadalafil as Adjuvant Therapy for DMD,RECRUITING,INTERVENTIONAL,"PHASE2, PHASE3",Duchenne Muscular Dystrophy,University of Florida,2021-12-14,2022-01-19,2024-01-31,2024-10-25T17:03:50.848735
NCT03951675,The Burden of Access in Duchenne Muscular Dystrophy in the US,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Florida,2019-06-18,2019-05-15,2020-08-06,2024-10-25T17:03:50.848735
NCT01359670,Tadalafil and Sildenafil for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,EARLY_PHASE1,Duchenne Muscular Dystrophy,Cedars-Sinai Medical Center,2011-05,2011-05-25,2020-01-14,2024-10-25T17:03:50.848735
NCT04335942,Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy",Assistance Publique - Hôpitaux de Paris,2021-09-30,2020-04-07,2023-08-31,2024-10-25T17:03:50.848735
NCT06402942,Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Gamification, Occupational Therapy",Başak Çağla Arslan,2024-09-01,2024-05-07,2024-07-18,2024-10-25T17:03:50.848735
NCT01519349,Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis,COMPLETED,INTERVENTIONAL,PHASE1,"Becker Muscular Dystrophy, Sporadic Inclusion Body Myositis",Nationwide Children's Hospital,2012-01,2012-01-26,2023-10-02,2024-10-25T17:03:50.848735
NCT02789059,Muscle Oxygenation in Effort in Neuromuscular Diseases,UNKNOWN,INTERVENTIONAL,NA,Neuromuscular Diseases,"University Hospital, Lille",2015-07-02,2016-06-02,2017-05-19,2024-10-25T17:03:50.848735
NCT06379906,"Upper Extremity Muscle Strength, Balance and Functional Skills in DMD",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Halic University,2023-11-10,2024-04-23,2024-04-25,2024-10-25T17:03:50.848735
NCT06103006,Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Lokman Hekim Üniversitesi,2021-01-01,2023-10-26,2023-10-27,2024-10-25T17:03:50.848735
NCT01557400,"Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada",COMPLETED,INTERVENTIONAL,PHASE3,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Dystrophinopathy",PTC Therapeutics,2012-05-20,2012-03-19,2020-11-25,2024-10-25T17:03:50.848735
NCT06579859,Development of a Registry to Assess Natural History in Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,2024-11-01,2024-08-30,2024-08-30,2024-10-25T17:03:50.848735
NCT06579352,Expanded Access Study of UC-MSC in DMD Patients,AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,MED Institute Inc.,,2024-08-30,2024-08-30,2024-10-25T17:03:50.848735
NCT01712152,Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study,COMPLETED,OBSERVATIONAL,,Carrier of Duchenne Muscular Dystrophy,Hospital Rudolfstiftung,2012-10,2012-10-23,2016-10-04,2024-10-25T17:03:50.848735
NCT00468832,Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD),UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2005-12,2007-05-03,2016-04-21,2024-10-25T17:03:50.848735
NCT01995032,L-citrulline and Metformin in Duchenne's Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne's Muscular Dystrophy (DMD),"University Hospital, Basel, Switzerland",2013-10,2013-11-26,2018-04-19,2024-10-25T17:03:50.848735
NCT05029232,Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital,UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Sohag University,2021-10-01,2021-08-31,2021-08-31,2024-10-25T17:03:50.848735
NCT01422200,Flu Vaccine Study in Neuromuscular Patients 2011,COMPLETED,INTERVENTIONAL,PHASE4,"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Congenital Muscular Dystrophy","Children's Hospital Medical Center, Cincinnati",2011-08,2011-08-23,2020-10-19,2024-10-25T17:03:50.848735
NCT02354352,Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Ohio State University,2015-03-20,2015-02-03,2019-10-07,2024-10-25T17:03:50.848735
NCT01197300,1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids,COMPLETED,INTERVENTIONAL,PHASE3,Osteoporosis,Novartis Pharmaceuticals,2010-10-25,2010-09-09,2019-09-20,2024-10-25T17:03:50.848735
NCT03836300,Parent and Infant Inter(X)Action Intervention (PIXI),ENROLLING_BY_INVITATION,INTERVENTIONAL,NA,"Fragile X Syndrome, Angelman Syndrome, Prader-Willi Syndrome, Dup15Q Syndrome, Duchenne Muscular Dystrophy, Phelan-McDermid Syndrome, Rett Syndrome, Smith Magenis Syndrome, Williams Syndrome, Turner Syndrome, Klinefelter Syndrome, Chromosome 22q11.2 Deletion Syndrome, Tuberous Sclerosis, Down Syndrome",RTI International,2018-11-30,2019-02-11,2024-05-01,2024-10-25T17:03:50.848735
NCT01386515,The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD),TERMINATED,OBSERVATIONAL,,"Genetic Disease, Communication",National Human Genome Research Institute (NHGRI),2011-06-07,2011-07-01,2019-12-12,2024-10-25T17:03:50.848735
NCT04193085,Wearable Technology to Assess Gait Function in SMA and DMD,COMPLETED,OBSERVATIONAL,,"Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy",Columbia University,2019-11-25,2019-12-10,2024-09-23,2024-10-25T17:03:50.848735
NCT05110885,"Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices",UNKNOWN,OBSERVATIONAL,,"Spinal Muscular Atrophy, Duchenne Muscular Dystrophy, Healthy Individuals",Bahçeşehir University,2021-11,2021-11-08,2021-11-10,2024-10-25T17:03:50.848735
NCT04281485,Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Pfizer,2020-11-05,2020-02-24,2024-09-19,2024-10-25T17:03:50.848735
NCT05160415,A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2021-12-28,2021-12-16,2024-06-14,2024-10-25T17:03:50.848735
NCT06445985,Hydrotherapy in Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Lancashire Teaching Hospitals NHS Foundation Trust,2022-11-02,2024-06-06,2024-06-06,2024-10-25T17:03:50.848735
NCT03443115,Duchenne Muscular Dystrophy Heart Study,UNKNOWN,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy",Hôpital Cochin,2017-06-27,2018-02-22,2018-02-22,2024-10-25T17:03:50.848735
NCT02516085,Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"University Hospital, Basel, Switzerland",2012-01,2015-08-05,2015-08-07,2024-10-25T17:03:50.848735
NCT02432885,Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial,COMPLETED,INTERVENTIONAL,PHASE3,"Myocardial Fibrosis, Muscular Dystrophies",InCor Heart Institute,2009-06,2015-05-04,2015-05-04,2024-10-25T17:03:50.848735
NCT01037309,Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2009-12,2009-12-23,2018-10-16,2024-10-25T17:03:50.848735
NCT03400852,A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Mallinckrodt ARD LLC,2018-07-27,2018-01-17,2021-03-16,2024-10-25T17:03:50.848735
NCT06093100,Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Vanderbilt University Medical Center,2024-07-10,2023-10-23,2024-09-19,2024-10-25T17:03:50.848735
NCT00750685,Study of the Mentor Becker Expander/Breast Implant in Subjects Who Are Undergoing Primary Breast Reconstruction,TERMINATED,INTERVENTIONAL,PHASE3,Breast Reconstruction,"Mentor Worldwide, LLC",2007-03-01,2008-09-10,2018-05-08,2024-10-25T17:03:50.848735
NCT01981915,Optimum Insufflation Capacity in NMD,COMPLETED,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Chronic Respiratory Insufficiency",Universität Duisburg-Essen,2011-01,2013-11-13,2013-11-13,2024-10-25T17:03:50.848735
NCT06366815,phenotypeS in Non Ambulant Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Natural History, Motor Function; Retardation",Fondazione Policlinico Universitario Agostino Gemelli IRCCS,2022-08-30,2024-04-16,2024-10-04,2024-10-25T17:03:50.848735
NCT02255552,Study of Eteplirsen in DMD Patients,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy (DMD),"Sarepta Therapeutics, Inc.",2014-11-17,2014-10-02,2021-01-25,2024-10-25T17:03:50.848735
NCT02251600,A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,PTC Therapeutics,2014-12,2014-09-29,2017-08-18,2024-10-25T17:03:50.848735
NCT05693142,AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,REGENXBIO Inc.,2023-01-04,2023-01-20,2024-07-23,2024-10-25T17:03:50.848735
NCT06643442,Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age,NOT_YET_RECRUITING,INTERVENTIONAL,PHASE2,DMD-associated Dilated Cardiomyopathy,Sebastiano Lava,2025-02-01,2024-10-16,2024-10-16,2024-10-25T17:03:50.848735
NCT05514249,Treatment of a Single Patient With CRD-TMH-001,UNKNOWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Cure Rare Disease, Inc",2022-08-31,2022-08-24,2022-09-01,2024-10-25T17:03:50.848735
NCT03368742,Microdystrophin Gene Transfer Study in Adolescents and Children With DMD,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Solid Biosciences Inc.,2017-12-06,2017-12-11,2024-10-15,2024-10-25T17:03:50.848735
NCT01153932,Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Muscular Dystrophies,GlaxoSmithKline,2010-09,2010-06-30,2014-08-25,2024-10-25T17:03:50.848735
NCT03057002,UTSW HP [13-C] Pyruvate Injection in HCM,RECRUITING,OBSERVATIONAL,,"Cardiomyopathy, Hypertrophic, Dilated Cardiomyopathy, Duchenne Muscular Dystrophy, Cardiac Sarcoidosis, Becker Muscular Dystrophy, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction",University of Texas Southwestern Medical Center,2018-05-01,2017-02-17,2024-02-05,2024-10-25T17:03:50.848735
NCT01865084,A Study of Tadalafil for Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",Eli Lilly and Company,2013-09,2013-05-30,2019-10-09,2024-10-25T17:03:50.848735
NCT03335384,Relationship Between PFTs and Pdi in DMD,WITHDRAWN,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Minnesota,2018-05-01,2017-11-07,2018-05-14,2024-10-25T17:03:50.848735
NCT01027884,Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Ambulatory Care",Santhera Pharmaceuticals,2009-07,2009-12-09,2015-10-19,2024-10-25T17:03:50.848735
NCT02420379,Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),"Sarepta Therapeutics, Inc.",2015-06-30,2015-04-17,2021-01-25,2024-10-25T17:03:50.848735
NCT03362502,A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Pfizer,2018-01-23,2017-12-05,2024-09-20,2024-10-25T17:03:50.848735
NCT02958202,Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2016-04,2016-11-08,2018-01-26,2024-10-25T17:03:50.848735
NCT01523964,DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Dart Therapeutics. LLC,2012-02,2012-02-01,2013-12-09,2024-10-25T17:03:50.848735
NCT01388764,"Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids",COMPLETED,INTERVENTIONAL,PHASE1,"Dystrophinopathy, Duchenne Muscular Dystrophy, Becker's Muscular Dystrophy",Massachusetts General Hospital,2012-01,2011-07-07,2012-07-03,2024-10-25T17:03:50.848735
NCT05689164,A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.,RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Pfizer,2023-03-13,2023-01-19,2024-02-22,2024-10-25T17:03:50.848735
NCT02472990,Biomechanical and Morphological Changes in Dystrophic Muscle,UNKNOWN,INTERVENTIONAL,NA,Duchenne Dystrophy Muscular,"University Hospital, Brest",2015-07,2015-06-16,2018-03-16,2024-10-25T17:03:50.848735
NCT01380964,Research of Biomarkers in Duchenne Muscular Dystrophy Patients,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy (DMD),Genethon,2011-06,2011-06-27,2016-08-17,2024-10-25T17:03:50.848735
NCT06128564,A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Hoffmann-La Roche,2023-11-29,2023-11-13,2024-10-22,2024-10-25T17:03:50.848735
NCT00674843,The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies,UNKNOWN,INTERVENTIONAL,PHASE1,Muscular Dystrophies,GAAD Medical Research Institute Inc.,2008-05,2008-05-08,2009-08-17,2024-10-25T17:03:50.848735
NCT04585464,"A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults",COMPLETED,INTERVENTIONAL,PHASE1,"Healthy Volunteer, Becker Muscular Dystrophy","Edgewise Therapeutics, Inc.",2020-10-12,2020-10-14,2022-06-28,2024-10-25T17:03:50.848735
NCT06304064,Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Capricor Inc.,2018-06-21,2024-03-12,2024-04-24,2024-10-25T17:03:50.848735
NCT00296621,Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Assistance Publique - Hôpitaux de Paris,2006-02,2006-02-27,2007-12-21,2024-10-25T17:03:50.848735
NCT03375164,A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2018-01-04,2017-12-15,2024-05-23,2024-10-25T17:03:50.848735
NCT02525302,HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Akashi Therapeutics,2015-05,2015-08-17,2019-03-12,2024-10-25T17:03:50.848735
NCT05096221,A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2021-10-27,2021-10-27,2023-11-07,2024-10-25T17:03:50.848735
NCT01918384,"Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy",UNKNOWN,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Kobe University,2013-08,2013-08-07,2015-09-03,2024-10-25T17:03:50.848735
NCT02485938,HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne),COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Duchenne Muscular Dystrophy, Cardiomyopathy",Capricor Inc.,2016-01,2015-06-30,2018-07-20,2024-10-25T17:03:50.848735
NCT03333590,Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Kevin Flanigan,2017-11-06,2017-11-07,2023-09-14,2024-10-25T17:03:50.848735
NCT02760264,A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2016-06,2016-05-03,2019-01-02,2024-10-25T17:03:50.848735
NCT05996003,NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2024-02-22,2023-08-16,2024-03-29,2024-10-25T17:03:50.848735
NCT00847379,Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD),TERMINATED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",PTC Therapeutics,2009-01-31,2009-02-19,2020-07-15,2024-10-25T17:03:50.848735
NCT05683379,AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,REGENXBIO Inc.,2022-12-20,2023-01-13,2024-07-18,2024-10-25T17:03:50.848735
NCT00654784,Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),Santhera Pharmaceuticals,2005-10,2008-04-09,2011-08-01,2024-10-25T17:03:50.848735
NCT06114056,"A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)",RECRUITING,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,West China Hospital,2024-01-22,2023-11-02,2024-01-17,2024-10-25T17:03:50.848735
NCT01125709,Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS),COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Cooperative International Neuromuscular Research Group,2010-01,2010-05-18,2013-01-11,2024-10-25T17:03:50.848735
NCT05166109,A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD),RECRUITING,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2022-07-07,2021-12-21,2024-08-19,2024-10-25T17:03:50.848735
NCT03531788,Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD,TERMINATED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Roxanna Marie Bendixen,2018-08-30,2018-05-22,2022-02-18,2024-10-25T17:03:50.848735
NCT04529707,Sleep Intervention in Young Boys With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Pittsburgh,2021-02-17,2020-08-28,2024-03-05,2024-10-25T17:03:50.848735
NCT06597656,A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74,RECRUITING,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2024-09-18,2024-09-19,2024-10-16,2024-10-25T17:03:50.848735
NCT01247207,Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD),ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,PTC Therapeutics,2010-11-30,2010-11-24,2024-10-09,2024-10-25T17:03:50.848735
NCT03433807,Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD),NO_LONGER_AVAILABLE,EXPANDED_ACCESS,,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,,2018-02-15,2023-04-21,2024-10-25T17:03:50.848735
NCT01603407,Finding the Optimum Regimen for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,University of Rochester,2013-01,2012-05-23,2022-08-12,2024-10-25T17:03:50.848735
NCT03796637,A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2019-04-11,2019-01-08,2022-04-05,2024-10-25T17:03:50.848735
NCT05209087,Effects of Parental Influence on Physical Activity Level and Participation in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",Hacettepe University,2020-03-01,2022-01-26,2022-09-09,2024-10-25T17:03:50.848735
NCT05066633,The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD,RECRUITING,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",Medical University of Gdansk,2021-08-18,2021-10-04,2021-10-04,2024-10-25T17:03:50.848735
NCT06100887,Phase 2 Study of EDG-5506 in Children and Adolescents with Duchenne Muscular Dystrophy Previously Treated with Gene Therapy (FOX),RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Edgewise Therapeutics, Inc.",2024-03-22,2023-10-25,2024-09-19,2024-10-25T17:03:50.848735
NCT02439216,Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne",Catabasis Pharmaceuticals,2016-04,2015-05-08,2022-09-23,2024-10-25T17:03:50.848735
NCT01874275,Duchenne Muscular Dystrophy Clinical Trial,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,"Alan Neuromedical Technologies, LLC",2013-06,2013-06-11,2015-05-04,2024-10-25T17:03:50.848735
NCT03439670,A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2018-06-29,2018-02-20,2023-03-09,2024-10-25T17:03:50.848735
NCT02847975,Sodium Nitrate to Improve Blood Flow,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2013-10,2016-07-28,2018-08-06,2024-10-25T17:03:50.848735
NCT00606775,The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,PHASE4,"Duchenne Muscular Dystrophy, Cardiomyopathies",Suzuka Hospital,2007-12,2008-02-05,2008-02-05,2024-10-25T17:03:50.848735
NCT01999075,Stacking Exercises Aid the Decline in FVC and Sick Time,COMPLETED,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Children's Hospital of Eastern Ontario,2013-03,2013-12-03,2018-12-24,2024-10-25T17:03:50.848735
NCT03603288,Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E),TERMINATED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2018-07-04,2018-07-27,2021-12-03,2024-10-25T17:03:50.848735
NCT06054971,NSAA NON-Interventional Study Protocol,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Red Nucleus Enterprise Solutions, LLC",2023-10-02,2023-09-26,2023-11-22,2024-10-25T17:03:50.848735
NCT00104078,Study Evaluating MYO-029 in Adult Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophy",Wyeth is now a wholly owned subsidiary of Pfizer,2005-02,2005-02-23,2007-12-28,2024-10-25T17:03:50.848735
NCT05849688,Bicycle Training on Ventilatory Functions in Duchenne Muscular Dystrophy,NOT_YET_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Beni-Suef University,2023-05-15,2023-05-09,2023-05-09,2024-10-25T17:03:50.848735
NCT00264888,Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2005-12,2005-12-13,2009-01-14,2024-10-25T17:03:50.848735
NCT06280209,"A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,BioMarin Pharmaceutical,2024-01-03,2024-02-28,2024-06-18,2024-10-25T17:03:50.848735
NCT04179409,"A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Kevin Flanigan,2020-02-18,2019-11-27,2023-10-26,2024-10-25T17:03:50.848735
NCT00018109,A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne",National Center for Research Resources (NCRR),,2001-07-05,2005-06-24,2024-10-25T17:03:50.848735
NCT02069756,The Duchenne Registry,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",The Duchenne Registry,2007-10,2014-02-24,2023-09-13,2024-10-25T17:03:50.848735
NCT01540409,"Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),"Sarepta Therapeutics, Inc.",2012-02-27,2012-02-28,2020-03-30,2024-10-25T17:03:50.848735
NCT03985878,"A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)",TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2019-06-26,2019-06-14,2023-08-18,2024-10-25T17:03:50.848735
NCT01484678,Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",University of Florida,2020-09-01,2011-12-02,2024-07-24,2024-10-25T17:03:50.848735
NCT02246478,A Study of TAS-205 for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2014-09,2014-09-22,2021-06-04,2024-10-25T17:03:50.848735
NCT03521271,Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2017-04-05,2018-05-11,2018-05-11,2024-10-25T17:03:50.848735
NCT01070511,Tadalafil in Becker Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE4,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2010-01,2010-02-18,2013-08-20,2024-10-25T17:03:50.848735
NCT04012671,A Registered Cohort Study on Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"Ning Wang, MD., PhD.",2019-07-01,2019-07-09,2021-03-22,2024-10-25T17:03:50.848735
NCT05661071,Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Hacettepe University,2022-05-11,2022-12-22,2022-12-22,2024-10-25T17:03:50.848735
NCT05967793,Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular Dystrophy,RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Egyptian Chinese University,2023-07,2023-08-01,2023-08-01,2024-10-25T17:03:50.848735
NCT06274983,DMD- Interactive Virtual Reality Study,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Sheffield Children's NHS Foundation Trust,2023-04-20,2024-02-23,2024-02-26,2024-10-25T17:03:50.848735
NCT02383511,Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne",Summit Therapeutics,2015-02,2015-03-09,2015-08-26,2024-10-25T17:03:50.848735
NCT01126697,Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3","Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy",Cooperative International Neuromuscular Research Group,2010-02,2010-05-20,2018-06-15,2024-10-25T17:03:50.848735
NCT02667483,Study of DS-5141b in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Daiichi Sankyo Co., Ltd.",2015-10,2016-01-29,2024-03-07,2024-10-25T17:03:50.848735
NCT00844597,Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2009-01,2009-02-16,2015-10-06,2024-10-25T17:03:50.848735
NCT01963897,"Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.",COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Oslo University Hospital,2013-08,2013-10-16,2017-09-25,2024-10-25T17:03:50.848735
NCT05641805,Physical Activity Level and Cognitive Functions in Children With Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Muş Alparlan University,2022-11-29,2022-12-08,2023-02-09,2024-10-25T17:03:50.848735
NCT02851797,Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Italfarmaco,2017-06-06,2016-08-02,2023-02-02,2024-10-25T17:03:50.848735
NCT02530905,Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2015-10-08,2015-08-21,2021-05-17,2024-10-25T17:03:50.848735
NCT02034305,Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Pittsburgh,2014-01,2014-01-13,2024-02-05,2024-10-25T17:03:50.848735
NCT02571205,Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Newcastle-upon-Tyne Hospitals NHS Trust,2015-11,2015-10-08,2021-04-13,2024-10-25T17:03:50.848735
NCT06412328,Psychoeducation Program for Parents of Children With DMD,COMPLETED,INTERVENTIONAL,NA,"Psychoeducation, Parents, Psychological Wellness, Duchenne Muscular Dystrophy",Lokman Hekim Üniversitesi,2023-06-21,2024-05-14,2024-05-14,2024-10-25T17:03:50.848735
NCT02810028,Acceptance and Commitment Therapy for Muscle Disease,COMPLETED,INTERVENTIONAL,NA,Muscle Diseases,King's College Hospital NHS Trust,2016-07,2016-06-22,2019-08-22,2024-10-25T17:03:50.848735
NCT05249361,Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Samsung Medical Center,2023-05-01,2022-02-21,2023-11-29,2024-10-25T17:03:50.848735
NCT00720161,Metformin in Children With Motor Deficit,COMPLETED,INTERVENTIONAL,NA,"Spina Bifida, Neuromuscular Diseases",Universitaire Ziekenhuizen KU Leuven,2006-11,2008-07-22,2024-06-17,2024-10-25T17:03:50.848735
NCT06485661,Effect of Captopril on GLS in Duchenne Myodystrophy,RECRUITING,INTERVENTIONAL,EARLY_PHASE1,Effect of Drug,Ain Shams University,2024-01-01,2024-07-03,2024-07-16,2024-10-25T17:03:50.848735
NCT00016653,Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE2, PHASE3","Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2000-06,2001-05-23,2011-10-27,2024-10-25T17:03:50.848735
NCT03963453,Regular Physical Exercise in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",Haukeland University Hospital,2021-02-01,2019-05-24,2023-03-01,2024-10-25T17:03:50.848735
NCT02760277,An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD),COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"ReveraGen BioPharma, Inc.",2016-07-28,2016-05-03,2019-07-23,2024-10-25T17:03:50.848735
NCT02286947,Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2014-11,2014-11-10,2020-03-30,2024-10-25T17:03:50.848735
NCT02653833,The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy,TERMINATED,INTERVENTIONAL,EARLY_PHASE1,Muscular Dystrophy,Cedars-Sinai Medical Center,2017-11-01,2016-01-12,2020-01-14,2024-10-25T17:03:50.848735
NCT04740554,Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,University of Sao Paulo,2013-03-01,2021-02-05,2021-02-05,2024-10-25T17:03:50.848735
NCT02020954,Prospective Becker-Heart-Study,UNKNOWN,OBSERVATIONAL,,"Dilated Cardiomyopathy, Lef Ventricular Dysfunction, Heart Failure",Karim WAHBI,2013-01,2013-12-25,2015-03-24,2024-10-25T17:03:50.848735
NCT01826487,Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2013-03-26,2013-04-08,2020-08-04,2024-10-25T17:03:50.848735
NCT01823783,"Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy",UNKNOWN,INTERVENTIONAL,NA,Duchenne Muscular Distrophy (DMD),"University Hospital, Montpellier",2012-11-07,2013-04-04,2020-02-07,2024-10-25T17:03:50.848735
NCT05524883,"Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping",RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Dyne Therapeutics,2022-08-12,2022-09-01,2024-10-24,2024-10-25T17:03:50.848735
NCT03642145,A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD),WITHDRAWN,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,PTC Therapeutics,2018-10-31,2018-08-22,2019-06-21,2024-10-25T17:03:50.848735
NCT05712447,Duchenne Muscular Dystrophy Video Assessment Registry,RECRUITING,OBSERVATIONAL,,Duchenne Muscular Dystrophy,"The Emmes Company, LLC",2022-09-01,2023-02-03,2023-12-18,2024-10-25T17:03:50.848735
NCT03002298,Virtual Reality in Individuals With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,University of Sao Paulo,2016-01,2016-12-23,2017-04-11,2024-10-25T17:03:50.848735
NCT01890798,Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol,WITHDRAWN,INTERVENTIONAL,PHASE3,Muscular Dystrophies,GlaxoSmithKline,2014-01,2013-07-02,2014-03-24,2024-10-25T17:03:50.848735
NCT01645098,Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy,Nationwide Children's Hospital,2011-08,2012-07-20,2015-02-26,2024-10-25T17:03:50.848735
NCT00592553,Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD),COMPLETED,INTERVENTIONAL,PHASE2,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy",PTC Therapeutics,2008-02-29,2008-01-14,2020-04-07,2024-10-25T17:03:50.848735
NCT00102453,Pentoxifylline in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2002-03,2005-01-31,2011-10-27,2024-10-25T17:03:50.848735
NCT02964377,Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents,COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,"Craig McDonald, MD",2016-11,2016-11-16,2021-12-21,2024-10-25T17:03:50.848735
NCT03508947,Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2018-01-24,2018-04-26,2019-04-08,2024-10-25T17:03:50.848735
NCT01480245,Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE3,Muscular Dystrophies,GlaxoSmithKline,2011-09,2011-11-28,2017-03-23,2024-10-25T17:03:50.848735
NCT05516745,"E-monitoring of PULMonary Function in Patients With Duchenne Muscular Dystrophy at Home""",RECRUITING,INTERVENTIONAL,NA,Duchenne Muscular Dystrophy (DMD),Medical University of Gdansk,2021-03-20,2022-08-26,2022-08-26,2024-10-25T17:03:50.848735
NCT04669847,The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD,COMPLETED,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne, Upper Extremity, Respiratory Functions",Gokce Yagmur Gunes Gencer,2018-04-07,2020-12-17,2020-12-17,2024-10-25T17:03:50.848735
NCT00819845,Ramipril Versus Carvedilol in Duchenne and Becker Patients,UNKNOWN,INTERVENTIONAL,PHASE4,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","Catholic University, Italy",2008-12,2009-01-09,2016-01-28,2024-10-25T17:03:50.848735
NCT00312247,Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Shriners Hospitals for Children,2006-04,2006-04-07,2015-05-19,2024-10-25T17:03:50.848735
NCT01099761,Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy,TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",2010-04,2010-04-08,2022-10-13,2024-10-25T17:03:50.848735
NCT05967351,A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study,ENROLLING_BY_INVITATION,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,"Sarepta Therapeutics, Inc.",2023-09-27,2023-08-01,2024-10-21,2024-10-25T17:03:50.848735
NCT01350154,"Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients",COMPLETED,INTERVENTIONAL,PHASE2,Becker Muscular Dystrophy,"Rigshospitalet, Denmark",2011-11,2011-05-09,2013-04-10,2024-10-25T17:03:50.848735
NCT04384354,Digestive Events in Duchenne Muscular Dystrophy Patients,COMPLETED,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Centre d'Investigation Clinique et Technologique 805,2007-01,2020-05-12,2020-05-12,2024-10-25T17:03:50.848735
NCT00839033,Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders,TERMINATED,INTERVENTIONAL,PHASE3,"Duchenne Muscular Dystrophy, Amyotrophic Lateral Sclerosis, Neuromuscular Diseases",Assistance Publique - Hôpitaux de Paris,2009-06,2009-02-09,2015-05-28,2024-10-25T17:03:50.848735
NCT05833633,Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations,RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",Fondazione Policlinico Universitario Agostino Gemelli IRCCS,2022-03-18,2023-04-27,2023-05-15,2024-10-25T17:03:50.848735
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-25T17:08:32.938258
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-25T17:08:32.938258
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-25T17:08:32.938258
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-25T17:11:04.848138
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-25T17:11:04.848138
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-26T15:45:56.748220
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-26T15:45:56.748220
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-26T15:45:56.748220
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-26T15:45:56.748220
NCT03589573,Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Muscle Strength, Lower Extremity, Hamstring Contractures",Hacettepe University,2017-03-24,2018-07-18,2018-07-31,2024-10-26T15:45:56.748220
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-27T22:37:50.965559
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-27T22:37:50.965559
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-27T22:37:50.965559
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-27T22:37:50.965559
NCT03589573,Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Muscle Strength, Lower Extremity, Hamstring Contractures",Hacettepe University,2017-03-24,2018-07-18,2018-07-31,2024-10-27T22:37:50.965559
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-27T22:39:10.848614
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-27T22:39:10.848614
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-27T22:39:10.848614
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-27T22:39:10.848614
NCT03589573,Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Muscle Strength, Lower Extremity, Hamstring Contractures",Hacettepe University,2017-03-24,2018-07-18,2018-07-31,2024-10-27T22:39:10.848614
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-27T22:41:20.302524
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-27T22:41:20.302524
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-27T22:41:20.302524
NCT05412394,Once Weekly Infant Corticosteroid Trial for DMD,RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,Anne M. Connolly,2021-04-30,2022-06-09,2023-09-18,2024-10-28T07:19:01.617518
NCT03529240,"Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption",COMPLETED,INTERVENTIONAL,NA,"Performance, Energy, Gait, Duchenne Muscular Dystrophy",Hacettepe University,2017-06-10,2018-05-18,2018-05-18,2024-10-28T07:19:01.617518
NCT01761292,"A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD",COMPLETED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy (DMD),Italfarmaco,2013-04,2013-01-04,2023-11-07,2024-10-28T07:19:01.617518
NCT05670730,Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping,ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2","Duchenne Muscular Dystrophy, Exon 44","Avidity Biosciences, Inc.",2022-11-09,2023-01-04,2024-09-23,2024-10-29T07:19:40.910850
NCT02994030,Biomarker for Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Increased Lordosis/Scoliosis, Hyporeflexia, Duchenne Muscular Dystrophy, Red-Green Color Blindness, Lordosis, Scoliosis, Muscular Atrophy, Muscular Weakness",CENTOGENE GmbH Rostock,2018-08-20,2016-12-15,2022-03-24,2024-10-29T07:19:40.910850
NCT00758225,"Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)",COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,Santhera Pharmaceuticals,2008-09,2008-09-25,2011-06-01,2024-10-29T07:19:40.910850
NCT02752048,A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2016-05,2016-04-26,2020-04-20,2024-10-30T07:18:11.016239
NCT04626674,A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-11-23,2020-11-12,2024-08-26,2024-10-30T07:18:11.016239
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-30T07:18:11.016239
NCT05639257,Treatment of Myotonia - Lamotrigine Versus Namuscla,RECRUITING,INTERVENTIONAL,NA,Non-Dystrophic Myotonia,"Grete Andersen, MD",2022-12-05,2022-12-06,2022-12-06,2024-10-31T07:18:10.182866
NCT06363357,"The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne, Orthotic Devices, Upper Extremity",Seoul National University Hospital,2024-04-20,2024-04-12,2024-06-21,2024-10-31T07:18:10.182866
NCT04322357,Twice Weekly Steroids and Exercise as Therapy for DMD,RECRUITING,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy (DMD),University of Florida,2020-07-30,2020-03-26,2024-01-31,2024-10-31T07:18:10.182866
NCT01633866,Pediatric Radio Frequency Coils Generic,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Musculoskeletal Abnormalities","Children's Hospital Medical Center, Cincinnati",2012-07,2012-07-04,2023-09-28,2024-11-01T07:18:57.538935
NCT00799266,An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids,COMPLETED,INTERVENTIONAL,PHASE3,Osteoporosis,Novartis Pharmaceuticals,2008-12-04,2008-11-27,2020-09-02,2024-11-01T07:18:57.538935
NCT03633565,Comparative Study of Strategies for Management of Duchenne Myopathy (DM),UNKNOWN,INTERVENTIONAL,PHASE4,Myopathy,Assiut University,2018-09,2018-08-16,2018-08-16,2024-11-01T07:18:57.538935
NCT00004646,"Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,National Center for Research Resources (NCRR),1995-04,2000-02-25,2005-06-24,2024-11-02T07:17:45.080812
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-11-02T07:17:45.080812
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-11-02T07:17:45.080812
NCT00004646,"Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,National Center for Research Resources (NCRR),1995-04,2000-02-25,2005-06-24,2024-11-03T07:17:42.252370
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-11-03T07:17:42.252370
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-11-03T07:17:42.252370
NCT00004646,"Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy",COMPLETED,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,National Center for Research Resources (NCRR),1995-04,2000-02-25,2005-06-24,2024-11-04T07:18:55.826425
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-11-04T07:18:55.826425
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-11-04T07:18:55.826425
NCT04184882,"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)",TERMINATED,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy (DMD),Astellas Pharma Inc,2021-02-24,2019-12-04,2024-10-22,2024-11-05T07:17:52.873621
NCT03179631,Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE3,"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn",PTC Therapeutics,2017-07-06,2017-06-07,2024-01-18,2024-11-05T07:17:52.873621
NCT02018731,L-citrulline and Metformin in Becker's Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker's Muscular Dystrophy (BMD),"University Hospital, Basel, Switzerland",2013-06,2013-12-23,2016-05-16,2024-11-05T07:17:52.873621
NCT03882827,Natural History of Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Genethon,2019-12-19,2019-03-20,2022-09-07,2024-11-06T07:18:04.228019
NCT03589573,Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Muscle Strength, Lower Extremity, Hamstring Contractures",Hacettepe University,2017-03-24,2018-07-18,2018-07-31,2024-11-06T07:18:04.228019
NCT02018731,L-citrulline and Metformin in Becker's Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Becker's Muscular Dystrophy (BMD),"University Hospital, Basel, Switzerland",2013-06,2013-12-23,2016-05-16,2024-11-06T07:18:04.228019
NCT03680365,Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Burden, Dependency, Disability Physical, Disease Management, Impairment, Rare Diseases","Jett Foundation, Inc.",2018-09-20,2018-09-21,2019-04-01,2024-11-07T07:17:28.778531
NCT01633866,Pediatric Radio Frequency Coils Generic,ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Musculoskeletal Abnormalities","Children's Hospital Medical Center, Cincinnati",2012-07,2012-07-04,2023-09-28,2024-11-07T07:17:28.778531
NCT01834066,Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2","Muscular Dystrophy, Duchenne Muscular Dystrophy,","Chaitanya Hospital, Pune",2014-09,2013-04-17,2014-09-17,2024-11-07T07:17:28.778531
NCT01847573,"Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy",TERMINATED,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Processa Pharmaceuticals,2013-05,2013-05-07,2020-09-03,2024-11-08T07:17:24.799256
NCT03067831,Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Stem Cells Arabia,2015-09,2017-03-01,2020-03-17,2024-11-08T07:17:24.799256
NCT02369731,Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",PTC Therapeutics,2015-04-30,2015-02-24,2024-10-09,2024-11-08T07:17:24.799256
NCT02434627,Sodium Nitrate for Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2015-06,2015-05-05,2020-01-13,2024-11-09T07:16:19.042964
NCT00033189,An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2001-09,2002-04-09,2010-11-16,2024-11-09T07:16:19.042964
NCT03552874,Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Limb Function, Respiratory Function Test",Hacettepe University,2017-01-01,2018-06-12,2018-06-12,2024-11-09T07:16:19.042964
NCT02434627,Sodium Nitrate for Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2015-06,2015-05-05,2020-01-13,2024-11-10T07:16:25.205162
NCT00033189,An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2001-09,2002-04-09,2010-11-16,2024-11-10T07:16:25.205162
NCT03552874,Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Limb Function, Respiratory Function Test",Hacettepe University,2017-01-01,2018-06-12,2018-06-12,2024-11-10T07:16:25.205162
NCT02434627,Sodium Nitrate for Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2015-06,2015-05-05,2020-01-13,2024-11-11T07:19:05.469589
NCT00033189,An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2001-09,2002-04-09,2010-11-16,2024-11-11T07:19:05.469589
NCT03552874,Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Limb Function, Respiratory Function Test",Hacettepe University,2017-01-01,2018-06-12,2018-06-12,2024-11-11T07:19:05.469589
NCT02434627,Sodium Nitrate for Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,Becker Muscular Dystrophy,Cedars-Sinai Medical Center,2015-06,2015-05-05,2020-01-13,2024-11-12T07:17:39.702398
NCT00033189,An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,"Muscular Dystrophy, Duchenne",Cooperative International Neuromuscular Research Group,2001-09,2002-04-09,2010-11-16,2024-11-12T07:17:39.702398
NCT03552874,Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy,COMPLETED,OBSERVATIONAL,,"Duchenne Muscular Dystrophy, Upper Limb Function, Respiratory Function Test",Hacettepe University,2017-01-01,2018-06-12,2018-06-12,2024-11-12T07:17:39.702398
NCT06363357,"The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,NA,"Muscular Dystrophy, Duchenne, Orthotic Devices, Upper Extremity",Seoul National University Hospital,2024-04-20,2024-04-12,2024-06-21,2024-11-13T07:17:46.966433
NCT06363526,Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.,NOT_YET_RECRUITING,INTERVENTIONAL,NA,"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Muscular Dystrophy",University of Malaga,2024-05-05,2024-04-12,2024-04-12,2024-11-13T07:17:46.966433
NCT05933057,"Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy",RECRUITING,INTERVENTIONAL,PHASE3,Duchenne Muscular Dystrophy,Italfarmaco,2024-02-19,2023-07-06,2024-11-11,2024-11-13T07:17:46.966433
NCT02484560,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,UNKNOWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,University of Gaziantep,2015-06,2015-06-29,2015-07-01,2024-11-14T07:18:34.776724
NCT04906460,Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2021-09-28,2021-05-28,2024-02-28,2024-11-14T07:18:34.776724
NCT00759876,Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2008-08-13,2008-09-25,2020-10-29,2024-11-14T07:18:34.776724
NCT00873782,Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophies, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy","University of North Carolina, Chapel Hill",2009-03,2009-04-02,2015-03-09,2024-11-15T07:19:24.926538
NCT04687020,Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-06-10,2020-12-29,2022-10-19,2024-11-15T07:19:24.926538
NCT02369731,Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",PTC Therapeutics,2015-04-30,2015-02-24,2024-10-09,2024-11-15T07:19:24.926538
NCT02436720,Upper Limb Assessment in Duchenne Muscular Dystrophy,UNKNOWN,OBSERVATIONAL,,Duchenne Muscular Dystrophy,Catholic University of the Sacred Heart,2013-01,2015-05-07,2015-05-07,2024-11-16T07:17:40.956347
NCT00873782,Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophies, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy","University of North Carolina, Chapel Hill",2009-03,2009-04-02,2015-03-09,2024-11-16T07:17:40.956347
NCT04626674,A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-11-23,2020-11-12,2024-08-26,2024-11-16T07:17:40.956347
